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ABSTRACT
The purpose of this study was to evaluate the current prevalence of
the metabolic syndrome with an emphasis on examining the relationship
between leisure time physical activity (LTPA) and the metabolic syndrome
in a nationally representative sample of the United States (U.S.) adult
population within the 1999-2004 National Health and Nutrition
Examination Survey (NHANES). The sample for.this study included adults
(N=5620), 20 years and older, who attended a mobile examination center
(MEC) examination in the NHANES 1999-2004. The American Heart
Association and National Heart, Lung, and Blood Institute (AHA/NHLBI)
AHA/NHLBI definition was used to define the metabolic syndrome based
on the results of a preliminary pilot study found in Appendix A. A metabolic
syndrome risk score (MSRS), ranging from Oto 5 was created to sum
cardiovascular (CV) risk factors. Accumulating a MSRS ?_3 designated a
metabolic syndrome diagnosis, a dependent variable within this study.
Physical activity (PA) was measured in two ways; a six-level measure of
MET·minutes per week, comprised of PA frequency, intensity, and
duration and a three-level variable (no leisure-time physical activity
(LTPA), insufficient LTPA, and an LTPA level equivalent to meeting the
CDC/ACSM PA recommendation) associated with the current Centers for
Disease Control and American College of Sports Medicine public health
PA recommendation (CDC/ACSM). SUDAAN statistical software was

iv

used to estimate age-adjusted prevalence and logistic and multi-logistic
odds risk ratios.
The overall age-adjusted prevalence of the metabolic syndrome
among the U. S. adult population was 36.3%. A significant difference was
found for metabolic syndrome prevalence between those meeting the
current public health PA recommendation (29.0%) and those reporting no
LTPA (40.0%). Adults who acquired between 736.55 and 1360.15
MET·min·wk-1 of LTPA were found to be 35% (OR 0.65; 95% Cl 0.48-0.88)
less likely to meet the AHA/NHLBI metabolic syndrome diagnosis criteria
compared to those reporting no LTPA. A similar inverse association was
found for an increasing the MSRS (OR 0.69; 95% Cl 0.56..;0.85)_. The
strength of this inverse association increased (OR 0.55; 95% Cl 0.42-0.71)
when weekly LTPA MET·minutes reached >1360.15 MET·min·wk- 1. This
inverse association was also found for an MSRS (OR 0.58; 95% Cl 0.48. 0.70) at this level of LTPA.
These findings estimate one in three U. S. adults have the metabolic
syndrome. This study consistently showed an inverse association between
LTPA and metabolic syndrome risk. Furthermore, there appeared to be a
stronger inverse association between metabolic syndrome and LTPA
when LTPA volume was increased. However, this additional decrease in
risk associated with increasing volumes of LTPA may likely revolve around
improvements in body composition. Improvements in body composition
associated with varying frequencies, intensities, and duration of PA may
V

improve other components defining the metabolic syndrome (i.e.
hypertension, obesity.) While this study is cross-sectional and causality
cannot be inferred due to the nature of self-reported data, our findings do
illustrate a strong inverse association for LTPA and the metabolic
syndrome. Researchers can feel confident that if LTPA is measured using
all three components (frequency, intensity, and duration) necessary to
calculate MET·min·wk- 1, that relationships with the metabolic syndrome
and its individual defining criteria will be detected. These results support
the need for future longitudinal studies and randomized control trials
examining PA volume and metabolic syndrome risk.
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PART I
INTRODUCTION

1

The clustering of multiple cardiovascular risk factors was first observed by
Kylin (3 1) in 1 923, when the Swedish physician reported three medical conditions
occurring together that he characterized as a syndrome. These conditions
included hypertension (HTN), hyperglycemia, and hyperuricemia. However, it
was not until 1 988 (42) that cardiovascular (CV) risk factor clustering became a
common focus for researchers. At this time, Reaven (42) described a series of
abnormalities called "Syndrome X", which included insulin resistance (IR),
glucose intolerance, hypertension (HTN), hyperinsulinemia, elevated very low
density lipoprotein (VLDL) triglycerides, and low high-density lipoprotein
cholesterol (HDL-C). Today, this constellation of cardiovascular risk factors which
now includes abdominal obesity (29) , is commonly known as the metabolic
syndrome, and is recognized as a global public health problem (51 ).
The metabolic syndrome has been shown to contribute to premature
morbidity and mortality resulting from cardiovascular disease (CVD) and type 2
diabetes (T2D), two of the leading causes of death worldwide (26, 38, 45). With
this in mind, the United States (U . S .) medical community recognized the
importance of diagnosing the metabolic syndrome by creating the International
Classification of Disease (IC0-9) Code . 277.7 for the Dysmetabolic syndrome
(1 3).
Despite the recognition by the medical community, only recently has the
prevalence of the metabolic syndrome in the U .S. population been widely
reported (1 5-1 7) . In fact, the first definition of the metabolic syndrome was
published by the World Health Organization (WHO) (4 7) in 1 999. Since the
2

creation of the WHO definition, there have been several definitions of the
metabolic syndrome published by various medical societies (1 , 1 3, 20, 24, 39).
Nevertheless, the core components are similar across all definitions and include:
IR or type 2 diabetes (T20), central obesity, HTN, and atherogenic dyslipidemia
(elevated triglycerides and low levels of high-density lipoprotein cholesterol
(HDL-C)). The most recent definition of the metabolic syndrome has been
developed by the American Heart Association (AHA) and the National Heart,
Lung and Blood I nstitute (NHLBI) (20), and represents an updated version of the
National Cholesterol Education Program (NCEP) (39) definition. To date, no
study has estimated the prevalence of metabolic syndrome according to the
AHA/NHLBI definition .
Central to these metabolic syndrome definitions are factors highly
associated with lifestyle, including smoking, alcohol consumption, diet, and
physical activity (PA). The positive impact regular PA has on cardiovascular risk
and overall health is well recognized (9). The Centers for Disease Control ar:,d
Prevention (CDC) and the American College of Sports Medicine (ACSM) have
established the public health recommendation that all Americans should
accumulate a minimum of 30 minutes of moderate-intensity PA on most if not all
days of the week or 20 minutes of vigorous-intensity PA on three days per week
(41). With this PA recommendation in mind, researchers have focused on the
impact of PA on individual CV risk factors (2, 2 1, 44, 48, 49). However, the first
study examining the association of PA with the clustered risk factors of the
metabolic syndrome was not conducted until 1998, when Wareham et al. (46)
3

reported that increasing total physical activity energy expenditure (PAEE)
reduced the risk (OR 0.32, 95%CI, 0.13-0.83) of the metabolic syndrome.
· Over the last decade, the body of literature examining the relationship
between PA and the risk of the metabolic syndrome has flourished. Several
cross-sectional (3, 5, 11, 12, 18, 19, 21, 22, 25, 28, 34-37, 40, 43, 50) and
longitudinal studies (4, 14, 27, 30, 32, 33) have been conducted. An all important
question within this literature is examining the relationship between the volume of
PA and the potential risk reduction of the metabolic syndrome. The frequency,
intensity, and duration of PA are the characteristics used to express the volume
of PA necessary to elicit a certain response (23). To date, only four studies (11,
18, 49, 50) have investigated the relationship between PA and the metabolic
syndrome using a national representative sample of U. S. adults. However, none
of these studies included data on all the components of PA volume (frequency,
duration, and intensity) necessary to fully examine the association of PA with the
risk of having the metabolic syndrome.
In _ the first study, which utilized the 1988-1994 Third National Health and
Nutrition Examination Survey (NHANES Ill) dataset, Park et al. (40) used a
physical activity intensity score (PAIS) to define physical inactivity while
examining the relationship between being inactive and having or not having the
metabolic syndrome. Individuals with a PA intensity score � 3.5 were designated
physically inactive and comprised 15 and 25 percent of adult males and females
respectively, in the U.S. population. In a multivariate odds ratio (OR) model
adjusting for ethnicity, BMI, smoking status, alcohol intake, carbohydrate intake,
4

education level, household income, and menopausal status, neither men (OR
1 .4; 95% Cl 1 .0-2.0) or women (OR 1 .2, 95% Cl 1 .0-1 .4) classified as physically
inactive were found to be at an increased risk for having the metabolic syndrome.
This suggests there is no relationship between physical inactivity and the
metabolic syndrome.
I n the second study utilizing the same NHANES Ill dataset, Zhu et al. (50)
examined the relationship of being active, moderately active, and sedentary with
the likelihood of having the metabolic syndrome as defined by National
Cholesterol Education Program (NCEP) in U .S. adults. Based on a PAIS, which
summated the weekly intensity in metabolic equivalents (METs) for each activity
performed to get an overall total MET score. Physical activity levels were defined
as follows: �1 5.0 (active), 3.6 to 1 4.9 (moderately active), and � 3.5 sedentary.
Both males and females in the active group were found to be significantly less
likely to have the metabolic syndrome compared to the inactive group (OR, 0.41 ;
95% Cl 0.31 -0.54) for males and (OR, 0.25; 95% Cl 0.1 8-0.37) for females.
Following adjustments for BMI , males were 73% less likely (OR 0.27, 95% Cl,
0.1 8-0.40) and females were 68% less likely (OR 0.32; 95% Cl, 0.21 -0.51 ) to
have the metabolic syndrome if they reported being active.
Additionally, Zhu et al. found that men and women who reported being
moderately active were 34% less likely (OR 0;66; 95% Cl, 0.48-0.89) and 31 %
less likely (OR 0.69; 95% Cl, 0.48-0.99) respectively, to have the metabolic
syndrome. However, among females, · after adjusting for age, race, education,
income, and menopausal status in the model, the relationship with PA
5

disappeared. While these findings in both the studies by Park et al. and Zhu et al.
illustrate an inverse relationship between PA and the metabolic syndrome, data
on the duration was not measured in NHANES Ill, so quantifying PA volume was
not possible.
In the third, which also used the NHANES Ill dataset, Du Bose et al. (11)
examined the relationship between PA and the metabolic syndrome by defining
PA with a three-level categorical variable, (inactive, irregularly active, and
regularly active) and metabolic syndrome based on the NCEP medical society
definition. Respondents acquiring � 5 d/wk of moderate PA for 30 minutes and/or
� 3 d/wk of vigorous PA for 20 minutes were considered regularly active, those
who reported some PA, however not � 5 d/wk of moderate or � 3 d/wk of
vigorous PA, were considered irregularly active. Participants who reported no PA
over the last 30 days were considered inactive. Irregularly active and inactive
men were found to be 52% (OR 1.52; 95% Cl, 1. 11-2.3 1) and 60% (OR 1.60;
95% Cl , 1 .18-1 .98), respectively, more likely to have the metabolic syndrome
. compared to regularly active men following adjustment for age, race, gender, and
education. In contrast, in women, physical inactivity was not found to be
associated with increasing risk of having the metabolic syndrome (OR 0.96 ; 95%
Cl 0.72-1.27) irregularly active and (OR 1. 18; 95% Cl 0.87- 1.59) inactive. · These
findings specific to women were consistent with previous studies (25, 33, 40).
In the most recent study examining the relationship between PA and the
metabolic syndrome, Ford et al. (18) utilized the 1999-2000 NHANES dataset · (6)
and included 1,626 subjects � 20 years of age who reported in a fasting condition
6

for a morning medical examination. During this examination, subjects were asked
to report the frequency and duration that they spent performing 43 different
leisure-time physical activities (LTPA) of moderate or vigorous intensity over the
previous 30 days (6). The total PA time in minutes per week (min/wk) was
calculated by summing the weekly minutes of participation for each intensity level
LTPA. A three-level categorical variable was then created: O min/wk, < 150
min/wk, and :: 150 min/wk.
In this study, after only controlling for age, adults who were physically
inactive were found to be 65% (OR 1.65; 95% Cl, 1.0 1-2.65) more likely to have
the metabolic syndrome than those reporting :: 150 min/wk of PA. However, after
controlling for gender, ethnicity, education, smoking status, and alcohol intake
this association was attenuated to the point of non-significance (OR 1.45; 95%
Cl, 0.86-2.44), yet when stratified by gender, women reporting no PA were over
twice as-likely to have the metabolic syndrome when compared to women ·
reporting :: 150 min/wk.(OR 2.35; 95% Cl, 1. 19-4.63). Physical inactivity was not
associated with the metabolic syndrome risk in men.
While the research described above illustrates the relationship between
PA and the metabolic syndrome, each study measured PA volume with only two
of the necessary three components. More specifically, the duration of each bout
of PA was not available in NHANES Ill (10), thus one of the necessary
components for more accurately assessing PA volume was missing. Also, the
investigators elected not to use available data on intensity (MET) level for each
specific activity in the1999-2002 NHANES dataset.
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An opportunity now exists to more accurately measure PA volume and its
relationship with the metabolic syndrome using the most comprehensive
measure of PA ever available in a nationally representative sample of U.S.
adults. This measure, MET minutes per week (MET·min·wk- 1 ) includes all the
necessary components to measure LTPA volume: frequency, intensity, and
duration. With this in mind, the purpose of this study was to estimate the current
prevalence of the metabolic syndrome while examining the relationship of LTPA
- · with the metabolic syndrome using the most recent six years in1 999-2004
NHANES (7).

Statement of the Problem
This study estimated the most recent prevalence of the metabolic
syndrome using a nationally representative sample of U.S. adults utilizing the
AHA/NHLBr definition. In addition, the relat1onship between LTPA and the risk of
the metabolic syndrome was examined. Particular emphasis was placed on the
relationship between LTPA and the metabolic syndrome utilizing MET-min·wk- 1 , a
more comprehensive measure of PA volume. Toward this end, these specific
research questions are posed below.

Research Questions
1. What is the current prevalence of the Metabolic Syndrome in the
United States adult population according to the American Heart
Association/National Heart, Lung, and Blood Institute definition?
8

2. Is there an inverse association for LTPA and the metabolic syndrome
when utilizing a measure of . LTPA volume (MET-min·wk-1)?
3. Is there an inverse association for LTPA and the metabolic syndrome
when measuring LTPA from the parameters of the CDC/ACSM
physical activity public health recommendation?

Significance of the Study

The purpose of this study is to examine the relationship between LTPA
and the Metabolic Syndrome metabolic syndrome in a nationally representative
sample of the U.S. adult population. This will be the first study to estimate the
current prevalence of the metabolic syndrome utilizing the AHA/NHLBI definition.

Delimitations

This study population was limited to U.S. adults aged 20 years and over
who participated in a fasting morning medical examination and health interview in
the1999-2004 NHANES (7). The NHANES is a collaborative effort between the
National Center for Health Statistics (NCHS) and the Centers for Disease Control
and Prevention (CDC) and is designed to provide national estimates of health
and nutritional status of the civilian noninstitutionalized population of the U.S.
aged two months and older (8). This study is delimited to only leisure-time
physical activity.

9

Limitations
Aspects of the1999-2004 NHANES may limit the findings in this study,
therefore the findings and discussion of the findings in this study must be
interpreted with caution. The limitations of this study are _described below.
1 . This was a cross-sectional study, thus causality cannot be established.
2. Data on PA and all covariates were measured by a self-report interview,
thus frequency, intensity, and duration of LTPA is subject to recall bias.
3. Leisure-time physical activity, smoking, and alcohol responses may have
been subjected to the social desirability effect (i. e. providing answers to
impress or please interviewer).
4. Dietary factors (i. e., caloric intake) were controlled in _this study due to -the
complex nature of this data inherent to 1999-2004 NHANES.
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The metabolic syndrome (MetS) has been recognized as a global public
health problem that is strongly linked as a seminal cause of cardiovascular
disease (CVD) and type 2 diabetes (T2D), both of which are responsible for
premature mortality and morbidity worldwide (108, 153, 207). The Mets is
characterized by the clustering of cardiovascular risk factors including insulin
resistance (IR or T2D), central obesity, hypertension (HTN), and atherogenic
dyslipidemia (elevated triglycerides and low levels of high-density lipoprotein
cholesterol (HDL-C)) (14, 65, 103, . 155, 223). Also, depending on the medical
society definition applied, microalbuminuria may also be considered another risk
factor (223).
The following review of the literature will discuss 1) a historical perspective ·
of cardiovascular risk factor clustering and the evolution of the Mets; 2) the most
commonly used working medical society definitions of the Mets ; 3) current
international and national prevalence estimates of the Mets; 4} the effects that
physical activity (PA) (or lack thereof) has on the individual components of the
Mets; and 5) review of all the studies done to date that have examined the
association of PA with the Mets, both cross-sectional and longitudinal.

Cardiovascular risk factor clustering and the metabolic syndrome
The constellation of metabolic risk factors and their deleterious effects on
cardiovascular health are well established (29, 84, 88, 14 1, 173, 229). Seminal
risk factor clustering for cardiovascular disease (CVD) was first reported by Kylin
(128) in the early 20th century. The Swedish physician described a syndrome
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involving the clustering of HTN, hyperglycemia and hyperuricemia (gout).
Subsequent work by Vague (2 12) reported a relationship between central
adiposity and diabetes, and Avogaro (11), adding obesity to Kylin's original
syndrome, strengthened the relationship between the clustering of Mets risk
factors and CVD. With continued interest on risk factor clustering and CVD,
Camus (35) coined an ensemble of CVD risk factors the 'deadly quintet' and
Jahnke (111) referred to a 'special metabolic syndrome ' in specific individuals.
For the first time in 1977, Haller and colleagues (91, 194) applied the term

"metabolic syndrome" when examining the convergence of obesity, diabetes
hyperproteinemia, hyperuricemia, and hepatic steatosis (fatty liver).
Reaven (173) drew immense attention to risk factor clustering and CVD in
his 1988 'Banting Lecture'. Frederick G. Banting was a Nobel Prize winning
physician who was one of the two men responsible for the discovery of insulin
(158). The 'Banting Lecture' is given every year by an expert in the area of
diabetes at the annual meeting of the American Diabetes Association (6).
Reaven described a constellation of risk factors leading to development of T2D
and CVD which he termed Syndrome X. Reaven postulated the etiology and
clinical course of three major related diseases - T2D, CVD, and HTN, all having a
common foundation of IR and hyperinsulinemia. However, at this time, adiposity
was not considered a major etiological factor.
In 1989, Kaplan (115) coined the term The Deadly Quartet to describe
upper-body obesity, glucose intolerance, hypertriglyceridemia, and hypertension.
However, this- addition of central adiposity was not novel. It was established 60
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years ago that upper-body obesity was a major player in the risk of developing
CVD (212). Subsequent work found that this quartet of conditions had a high
level of agreement more commonly than by chance (5, 115).
Hypertriglyceridemia, HTN, and T20 have been found to be much more
prevalent in obese compared to nonobese individuals (196, 213). Modan et al.
(151) found a twofold increase in obesity and T2D among individuals with HTN
versus their normotensive counterparts. In addition, dyslipidemia has also been
found to be associated with IR, obesity and the Mets (26, 79).
The name Insulin Resistance Syndrome (I RS) was first used in 1992 in a
prospective analysis examining the association of hyperinsulinemia (used as
proxy for IR) and incidence of HTN, T2D, and dyslipidemia over an eight year
follow-up in the San Antonio Heart Study (88): The San Antonio Heart Study was
a population-based study conducted in San Antonio, Texas. Mexican-American
and non-Hispanic White men and nonpregnant women, aged 25-64 years, were
randomly selected from all levels of socioeconomic status to examine the effects
of the clustering of conditions described above on CVD incidence. This
prospective analysis illustrated that hyperinsulinemia at baseline significantly
increased the relative-risk of T2D five-fold, hypertriglyceridemia three-fold, HTN
. two-fold and the presence of low HDL-C by 60%. Zavaroni et al. (231) found
similar results in a prospective study when testing the hypothesis that
hyperinsulinemia was positively associated with glucose intolerance,
dyslipidemia, elevated uric acid concentrations, and HTN. Interestingly, in both of
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the above studies these changes were independent of level of adiposity
(obesity).
Visceral obesity, IR, and dyslipidemia were assigned the name
"plurimetabolic syndrome" by Despres (49) when examining how aerobic
exercise influenced this trio of cardiovascular risk factors. In the Bruneck Study,
which examined the prevalence of IR in metabolic disorders, the coexistence of
IGT or T2D, dyslipidemia, hyperuricemia, and HTN were also designated the
"plurimetabolic syndrome" (30). Given the metabolic nature of the syndrome, the
name "metabolic syndrome" as proposed by Haller (91) has been rcognized as
the most appropriate label by the clinical and research communities.

Different medical society definitions of the metabolic syndrome

In establishing an official diagnosis for the Mets, the American
Association of Clinical Endocrinologists (AACE) championed the creation of the
International Classification of Disease-9th revision (I CD-9) Code 277.7 for the
Mets (65). Currently, · there are currently five . working medical society definitions
proposed for the diagnosis of the Mets. Table 1 summarizes the various
definitions published by the following medical societies: .1) World Health
Organization (WHO) (223), 2) European Group for the study of Insulin
Resistance (EGIR) ( 14), 3) American Heart Association (AHA) and the National
Heart, Lung and Blood Institute (NHLBI) definition (85) which refers to the
updated National Cholesterol Education Program (NCEP) (2001) definition, 4)
the American College of Endocrinology (ACE) and American Association of
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Clinical Endocrinologists (AACE) consensus definition for epidemiological
research (65), and 5) the International Diabetes Federation (IDF) (103).

AHAINHLBI (updated NCEP)
The majority of the recent research focusing on the metabolic syndrome
involved the use of the NCEP definition because of its clinical utility (See Table
1 ). The NCEP definition requires that three of the following five criteria be present
for a diagnosis of the metabolic syndrome: impaired fasting glucose (I FG)
represented by a fasting blood sugar � 110 milligrams per deciliter (mg/d l),
including type 2 diabetes (T2D); HDL-C < 40 mg/d l in men and < 50 mg/d l in
women; triglycerides � 150 mg/dl; an augmented waist circumference 0/VC) of >
102 centimeters (cm) in men and > 88 cm in women, or a blood pressure value of _
> 130/BS millimeters of mercury (mmHg). The NCEP definition is-unique to the

other metabolic syndrome definitions in the respect that it precludes specific
inclusion criteria of any one condition (e.g. I FG) in order for metabolic syndrome
to be diagnosed. The most recent definition put forth by the AHA and N H LBI (85)
mirrors the NCEP definition with the following modifications: medication use for
those with dyslipidemia, HTN, and I FG maintains the diagnosis, and the . cut-off
point for I FG was lowered from 110 mg/d l to 100 mg/d l to reflect the recent
changes put forth by the American Diabetes Association (ADA) for IFG (2).
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The WHO metabolic syndrome definition includes at least one of the
following requisite conditions: impaired glucose tolerance (IGT) following an oral ··
glucose tolerance test (OGTT); t FG (� 110 mg/dl), including T2D; or insulin
levels in the top quartile of the population; plus 2 of the following: HDL-C < 35
mg/dL in men or 39 mg/dL in women or elevated triglycerides (� 150 mg/dL), a
waist to hip (W:H) ratio >0.9 for men or >0.85 for women, or body mass index
(BMI) > 30 kilograms per meters squared (kg/m 2 ) in men or women, BP � 140/90
mm/Hg, or microalbuminuria represented by a albumin creatinine ratio � 30
milligrams per gram (mg/g).

The EGIR definition requires insulin in the upper quartile of the
background population, plus any 2 of the following:· HDL-C < 1.0 millimole per
· liter (mmol/L) or 40 mg/dL or treatment for dyslipidemia, triglycerides > 2.0
mmol/L (180 mg/dL) or treatment for dyslipidemia, WC of � 94 cm for men and �
80 cm for women, blood pressure � 140/90 mmHg or treatment for HTN, or IGT
following a oral glucose tolerance test (OGTT) or IFG (?: 11Omg/dl), but not
diabetes.

The IDF definition requires an augmented WC in Europeans and
Americans of � 94 cm for men and � 80 cm for women. However, the IDF
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recommends WC cut-off points that are population and/or ethnic specific with
values of � 90 cm and � 80 cm in South Asian and Chinese men and women,
respectively, and values of � 85 cm and � 90 cm in Japanese nien and women,
respectively (234). In. addition to a requisite for an augmented WC, 2 of the
following conditions must be present for metabolic syndrome diagnosis: IFG
represented by a fasting blood sugar � 100 mg/dl, including T2D; HDL-C < 40
mg/dl in men and < 50 mg/dl in women or treatment for lipid abnormality;
triglycerides � 150 mg/dl or treatment for lipid abnormality; or a blood pressure
value of � 130/85 mmHg or treatment for HTN.

ACE/AA CE
The ACE/AACE definition requires one of the following: an individual to be
classified as high risk (See Table 1); BMI >25 kg/m2 or WC of >102cm in men or
>88cm in women, plus > 2 of the following: IFG (� 110 mg/dl ) or IGT following a
OGTT, but not diabetes; HDL-C < 40 mg/dl in men or < 50 mg/dl in women;
elevated triglycerides (> 150 mg/dl); or a BP > 130/85 mm/Hg.
Metabolic syndrome prevalence has been shown to vary depending on
which medical society definition is adopted (75, 76). Several prevalence studies
have compared multiple definitions (15, 46, 51, 130, 215), however, since there
is no consensus among definitions and various working definitions are continuing
to be employed in both clinical and epidemiological research, comparisons
between studies continues to be a difficult task. The following section will

26

examine the current international and national prevalence estimates of the
metabolic syndrome.

Current prevalence estimates

It is estimated that close to one billion people worldwide have the
metabolic syndrome (64) . Global prevalence estimates of the metabolic
syndrome vary considerably, depending on the population under study, definition
applied, and study design utilized. The increasing number of people with the
metabolic syndrome can be attributed in part to population growth, aging, excess
caloric intake, and an inactive lifestyle (169). There have been numerous
population based cross-sectional (7, 9, 12, 34, 58, 72, 73, 75-77, 86, 112, 123,
139, 147, 157, 165, 167, 171, 203, 215) and cohort studies (145, 148) done that
have estimated the metabolic syndrome prevalence. Among these studies, only
12 have estimated the prevalence of the metabolic syndrome utilizing a nationally
representative sample of adults (7, 9, 31, 33, 34, 73, 75-77, 86, 119, 161). The .
following section will examine all the cited - prevalence studies that utilized a
national representative sample, starting with the international studies, followed by
the national (U. S.) studies.

International prevalence estimates

In the Australian, Obesity, and Lifestyle Study (AusDiab), which was a
national population-based cross-sectional survey of the prevalence of diabetes
and other cardiovascular risk factors in people aged � 25 years, the prevalence
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estimates of the metabolic syndrome were reported utilizing three different
definitions (33). Overall prevalence estimates from the AusDiab were reported to
be 15.9% for the EGIR definition, 18.3% for the NCEP definition, and 20.9% for
the WHO definition. The same research group, utilizing the WHO and NCEP
definitions, reported the prevalence estimates of the metabolic syndrome
originating from a national sample of Mauritians (34 ). Mauritians are comprised of
a mixture of Indians, Creoles, Chinese, Europeans, Zarabes, Kaffirs and
Malabars living on a sub-continent off the coast of India. The metabolic syndrome
prevalence estimates in this highly heterogeneous group were found to be 19.1 %
(WHO) and 13.8% (NCEP).
The estimated prevalence of the metabolic syndrome in Greece was
reported in a cross-sectional analysis of a representative sample of Greek adults
participating in the Metabolic Syndrome-Greece Multicentre Study (8). The
estimated prevalence of the metabolic syndrome originating from this national
sample was 23.6% utilizing the NCEP definition. In cross-sectional survey of a
national representative sample of White, Black, Amerindian, and Mixed Hispanics
� 20 years of age in Venezuela, the prevalence of the metabolic syndrome and
its associated risk factors was identified (73). The estimated prevalence of the
metabolic syndrome was reported to be 3 1.2% utilizing the NCEP definition. This
was the first national study examining metabolic syndrome prevalence in South
America.
The International Colfaborative Study of Cardiovascular Disease in ASIA
(InterASIA) was a cross-sectional study of CVD risk factors in a national sample
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of Chinese adults (86). Utilizing the NCEP criteria, the estimated prevalence
among Chinese adults was 13.7%. However, the NCEP criteria may not be
appropriate for Asian populations (93 , 224). Subsequently, adjustments for the
HDL-C cut-off point being � 1.0 mmol/L for both men and women and WC cut-off .
points being lowered to > 90 cm for men and > 80 cm for women increased the
metabolic syndrome prevalence estimate in Chinese adults to15. 1 %�
The estimated prevalence of the metabolic syndrome in Japan was
recently reported in a national survey of adults aged 20-79 years (7). This study
utilized the new definition released from the Japanese Committee for the
Diagnostic Criteria of the metabolic syndrome. The Japanese metabolic
syndrome definition requires the presence of abdominal obesity defined as a WC
of � 85 cm in men and .:: 90 cm in women, plus 2 of the following: triglycerides �
150 mg/dL and/or HDL-C < 40 mg/dL or treatment for dyslipidemia; blood
pressure .:: 130/85 mm/Hg or treatment for HTN; and I FG .:: 110 mg/dL or
treatment for diabetes. Participants taking medication for dyslipidemia were
excluded in this study °because data allowing differentiation of treatment for
hypercholesterolemia or hypertriglyceridemia could not be obtained. In Japanese
adults, the national metabolic syndrome prevalence was estimated to be 7.8%.
In the Korean National Health and Nutrition Examination Survey
(KHANES), the prevalence of the metabolic syndrome was estimated in over
4,000 Korean adults (119). This study was conducted to compare prevalence
estimates of the metabolic syndrome as defined by the I OF and NCEP, and the
obesity criteria put forth by the WHO and the Korean Society for the Study of
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Obesity (KSSO) (136). The WHO WC cut-points in Korean adults are � 90 cm in
men and � 80 cm in women. The WC cut-points according to the KSSO are � 90
cm in men and � 85 cm in women. The WHO recommendation lowers WC cut
point in men by 5 cm and utilizes the same lDF cut-points in women. The KSSO
also lowers WC recommendations to � 90 cm in men; however, the women cut
point is raised 5 cm above the IDF criteria.
The age-adjusted prevalence of the metabolic syndrome within the
KHANES was estimated to be 23.8% and 17 .5% utilizing the modified 1DF
definition and WHO obesity criteria, and modified IDF definition and KSSO
obesity criteria, respectively (1 19). The age-adjusted prevalence estimates for
the NCEP modified by the WHO definition and the NCEP modified by KSSO
definition were 26.7% and 23.7%, respectively. The prevalence of the metabolic
syndrome as defined by NCEP, modified by the WHO, was the highest (26.7%;
95% Cl, 26.0-27.4), while the prevalence of the metabolic syndrome defined by
the IDF modified by the KSSO was the lowest 17.5%, 95% Cl, 16.9-18. 1). This
study clearly illustrated how metabolic syndrome definition (and definition
modification) can impact prevalence estimates.
In a study examining PA and the metabolic syndrome in Canada, the ·age
adjusted national prevalence of the metabolic syndrome was also estimated (3 1)
utilizing a modified NCE P definition in the Canadian Heart Health Survey
(CHHS). The CHHS was a series of national representative cross-sectional
surveys of CVD risk factors in Canadians aged 18-74 years, conducted between
· 1986 and 1992. Data on glucose and WC values were only obtained on half of
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the participants, therefore self-reported physician diagnosed T2D was substituted
for glucose, and BMI was used in place of WC. The age-adjusted estimated
metabolic syndrome prevalence in Canadian adults surveyed between 1 986 and
1992 was 1 4.4%.

Prevalence estimates in the United States
In the U.S., Ford et al. (77) first reported the estimated prevalence of the
metabolic syndrome in a national representative sample of adults, aged � 20
years, utilizing data from the 1988-1994 Third National Health and Nutrition
Examination Survey (NHANES I l l) (4 1). NHANES I l l was a cross-sectional health
survey of a national representative sample of noninstitutionalized U.S. adults.
The estimated age-adjusted prevalence of the metabolic syndrome utilizing the
NCEP criteria was found to be 23 .7%. This was the first report of metabolic
syndrome prevalence estimates in the US. In a follow-up study utilizing the same
NHANES Ill data, Ford et al. (76) reported the prevalence of the metabolic
syndrome comparing two different medical society definitions, the WHO definition
and NCEP definition. The estimated age-adjusted prevalence of the metabolic
syndrome utilizing the WHO definition was 25.1 % and the NCEP definition w·as
23.9%. These two prevalence estimates were not significantly different. Ford et
al. reported that the reason the prevalence estimates utilizing the same data set
and NCEP definition varied slightly from the first prevalence estimates (77) was
due to differences in the analytical sample sizes.
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The most recent prevalence estimate of the metabolic syndrome in the
U.S. were reported by Ford et al. (75) utilizing the newly released IDF definition
( 103). This study also used 1999-2002 NHANES (39). In addition to estimating
metabolic syndrome prevalence using IDF definition, this study also ex.amine�
prevalence using the NCEP definition. The age-adjusted national prevalence
· estimates for the metabolic syndrome were found to be - 3 9.1 % (IDF) and 34.6%
(NCEP). These two prevalence estimates were found to be significantly different, .
illustrating for the first time in a national sample of U.S. adults, how the metabolic
syndrome definition applied can impact prevalence.
A cross-sectional examination of the last two releases of the NHANES
(1988-1994 and 1999-2002) data illustrates a 10% increase in the prevalence of
the metabolic syndrome in US adults, depending on the definition applied (75,
77). With the metabolic syndrome becoming more common in Westernized
societies (64), the prevalence and incidence are anticipated to increase in line
with the prevalence and incidence of obesity ( 152) and T2D (225).

Physical activity and defining metabolic syndrome criteria
Insulin resistance and physical activity
PA and its positive effects on blood sugar control were first observed in
the early part of the twentieth century ( 170). Regular physical activity has been
shown to improve rates of glucose uptake in a similar fashion to insulin. M uscle
fiber contraction increases the number and activity of glucose transport proteins i :
GLUT-4, in skeletal muscle (83, 97). Thus, contracting skeletal muscle has
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'insulin like effects ' on glucose uptake. Furthermore, contracting skeletal muscle
does not require_ the presence of insulin in order to take up glucose.
Reaven (172, 173) and others (45, 69) have clearly illustrated I R to be the
core component of the metabolic syndrome. It has been found to be present in
approximately 25% of western society (22, 45, 173). The etiology of I R involves
diminishing beta-cell function over time, and has been estimated to result in IGT
and eventually frank T2D approximately 30%-40% of the time (218). Saltin et al.
(186) demonstrated that a low aerobic capacity, expressed per kilogram of body
weight, may manifest itself as an early component of the metabolic syndrome,
particularly in individuals likely to go on to develop T2D. Furthermore, histological
evidence has demonstrated that I R/hyperinsulinemic individuals have attenuated
mitochondrial and capillary density in skeletal muscle , accompanied by a
decreased type I versus type I I fiber ratio (146). Therefore, genetic abnormalities
in skeletal muscle may limit aerobic capacity, thus resulting in lower levels of .. .
physical activity.
Several cross-sectional studies have illustrated that individuals- who
reported performing large amounts of aerobic PA on a consistent basis . present
with lower serum insulin levels, both in the fasting and postprandial state (21, 63,
178). Similar effects have been reported in older men and women (181, 182,
190). Therefore, regular PA also appears to insulate individuals from the
deleterious effects of glucose intolerance associated with the normal aging
process. When examining insulin sensitivity and glucose uptake in PA
intervention studies, acute bouts of PA (28) and lifestyle changes including
33

regular aerobic (101, 199, 200) and strength training activities (114, 149) have
been shown to enhance insulin sensitivity, thus improving glucose control in
subjects with varying levels of glycemia and BMI (142, 210).

Hypertension and physical activity
Essential (i.e., no known cause) HTN is a heterogeneous condition which
has been shown to be associated with hyperinsulinemia (45, 68, 70, 71, 173,
176). Hypertension has been studied more than any other condition defining the
metabolic syndrome (43, 67, 89, 94, 104, 174, 191, 195, 197, 232). As reported
by the Seventh Joirit National Committee on Prevention, Detection, Evaluation,
and Treatment of High Blood Pressure (JNC VI I) (43), approximately 25% of the
US population is estimated to be hypertensive as classified by a systolic blood
pressure (SBP) � 140 mmHg, a diastolic blood pressure (DBP) � 90 mmHg or
taking anti-hypertensive medication. It has also been estimated that another 22%
of the US population falls into the prehypertension category which is classified as
a SBP between 120-139 mmHg or a DBP that falls between 80-89 mmHg. This
prehypertension category carries with it a recommendation for lifestyle changes
before introducing pharmacological treatment (43). These changes, which are
also recommended for individuals with diagnosed HTN, include increasing the
amount of regular PA and making healthy dietary changes (e.g., sodium
restriction) leading to weight loss to help prevent the development of HTN.
Regular PA has been shown to be associated with more favorable blood
pressure (BP) values (18, 89). Tanaka et al. (201) found a decrease in both
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sitting and supine SBP in 18 previously sedentary subjects with stage 1 and
stage 2 HTN following 10 weeks of supervised swimming. Dengel et al. (47)
reported decreases in both SBP and DBP following nine months of aerobic PA,
three days per week a·nd gradually reaching 40 minutes per session. Similar
findings were reported by Fagard (67) demonstrating a decrease in BP in both
normotensive and hypertensive individuals, however the effect was more
pronounced in the hypertensive group.
Ishikawa et al. (107) reported a significant drop in blood pressure in both
sedentary men and women age 30-69 years with stage 1 and 2 hypertension
following an eight week PA program. In addition, this study demonstrated no
differences in the efficacy of PA between genders; however, the older
hypertensive subjects experienced less of a reduction in BP following the
exercise program than their younger counterparts. Similar reductions in both SBP
and DBP were reported by Swartz et al. (200) following an eight week walking
program of 10,000 steps per day in overweight women. Overall, regular PA has
been shown to decrease SBP and DBP in nearly 75% of people with HTN (89).

Dyslipidemia and physical activity
Atherogenic dyslipidemia commonly associated with the metabolic
syndrome is represented by elevated triglycerides and decreased- levels of HDL- ·
C, particularly HDL2-C (25, 26, 175) which is associated with cardioprotection.
The Diabetes Prevention Program (OPP) Research group (Rockville, MD) (50)
reported that individuals with IGT, compared with individuals who go on to
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develop T2D, were very similar. Individuals with either IGT or T2D showed
minimal differences in BP; triglycerides; HDL-C or non-HDL-C; or low-density
lipoprotein cholesterol (LDL-C); implying that cardiovascular risk factor profile for .
T2D differs very little from that of IGT. This suggests that the IR phenotype may
be primarily responsible for the dyslipidemia characteristic of hyperglycemia.
Regular PA has been shown to demonstrate favorable effects on lipid
profiles (6 1, 226 , 227). PA can augment the capacity of muscle tissue to take up
and oxidize non-esterified fatty acids (25, 6 1) and increase the activity of
lipoprotein lipase (LPL) in muscle (164). Individuals who engage in regular PA,
compared to those who are physically inactive, have been found to have higher
levels of HDL-C and HDL2-C, in addition to lower levels of triglycerides and LDL
C. In contrast, limited evidence exists demonstrating that individuals who are
physically active possess lower levels of total cholesterol (TC) and LDL-C (12 1,
122, 133). Hence, some lipids and lipoproteins are _more favorably impacted by
exercise and PA than others (59).
There have been several studies examining the relationship between
volume of PA and changes in blood lipid levels (52, 53, 120, 1 24, 1 33 , 226, 227).
Drygas et aL (52) found HDL-C to be· approximately 6 mg/dL greater in men who
were physically active when compared to the least active group. In a similar
study design, Kokkinos et al.- ( 120) reported an inverse association between
miles run per week and TG levels, and a positive association between HDL-C
and miles run per week in a group of middle-aged men. In women, similar results
have been reported. Durstine et al. (62) reported HDL-C levels were greater in
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female recreational runners and even greater in female elite runners versus their
sedentary counterparts, thus demonstrating a favorable positive association. The
positive association between HDL-C levels and running volume were similar for
men and women, however TG and TC:HDL-C ratios remained intact (226).
The frequency of favorable changes reported in HDL-C and TG levels
following regular PA suggests that these lipid values are more responsive to
regular PA than TC and LDL-C (60). Although regular PA results in minimal
changes in TC and LDL-C in the absence of weight loss (198), the
concentrations of LDL-C, particularly small dense LDL-C has been shown to
decrease, while LDL-C particle size is augmented, resulting in a less atherogenic
environment ( 124). Regular PA has also been shown to have favorable effects
on the atherogenic dyslipidemia associated with the metabolic syndrome (27 , 50,
60). In addition, prospective studies ( 124, 204, 226, 227) have confirmed ·
additional improvements in these lipid values with increases in the volume of PA
performed, thus suggesting a potential dose-response association.

Obesity and physical activity
In a recent 2006 study, Ogden et al. (159) reports the current prevalence
of overweight and obesity in the U .S. adult population to be 66. 5%. The
metabolic syndrome has been shown to be linked to increased levels of
abdominal or central adiposity (19, 20, 45, 48, 75, 77, 116, 160, 161, 179). Upper ·
body obesity, formerly known as android obesity (211) carries the highest level of
cardiovascular risk and is ubiquitous among the defining criteria in all the working
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definitions of the metabolic syndrome (14, 65, 85, 103, 155, 223). Regional fat
distribution studies performed with computed topography (CT) scanning and dual
energy x-ray absorptiometry (DEXA) have demonstrated that higher levels of
visceral adiposity are related to greater degrees of I R and HTN (44, 81), thus
creating a more atherogenic environment. However, these findings are not
consistent across racial groups (13).
High levels of physical inactivity have been reported to be the seminal
etiology in the rapid rise in obesity rates (127, 168). Regular bouts of PA have
been shown to improve percent body fat and body fat distribution. In a cross
sectional study, Troisi et al. (208) found both BMI and waist to hip ratio to be
inversely associated with regular PA. In NHANES I ll, women who met or
exceeded the Centers for Disease Control and Prevention and the American
College of Sports Medicine (CDC/ACSM) public health recommendation for PA
(162) were found to have lower BMI, percent body fat, and waist to hip ratios
compared to those not meeting the recommendation or reporting being physically
inactive (96).
Folsom et al. (74) reported in a study of 25-74 year old men and women,
that adults expending 2, 000 kilocalories (kcals) per week in leisure time physical
activity (LTPA) had significantly lower BMI values. Similar results were seen in
the Bogalusa Heart Study (87). This study examined reported levels of leisure
time PA (L TPA) and physical inactivity and found LTPA to be inversely related
with BMI and WC. I n- contrast, a cross-ove.r design study consisting of 22 healthy,
slightly overweight, sedentary men resulted in little change in body weight,
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percent body fat, BMI or overall cardiovascular risk profile following 1 2 weeks
moderate to vigorous PA ( 138). One explanation for this m ay be low levels of
non-LTPA (domestic activities), which have been shown to reduce CVD risk at
higher levels (22 1).
Findings from several prospective studies suggest that overweight and
obesity may be more due to low levels of energy expenditure and not
hyperphagia (118, 168, 228). Prospective studies however, have shown
moderate amounts of PA result in small to moderate weight loss when compared
to hypocaloric diets alone (95, 126, 137, 163, 188, 222). Nonetheless, several
recent prospective studies have demonstrated that combining regular PA with a
weight loss program in individuals at increased risk for developing the metabolic
syndrome can have favorable effects on the metabolic profile, thus reducing the
risk of the metabolic syndrome (50, 1 42, 2 1 0, 220). Therefore, adding PA to any
prescribed weight loss program would be prudent. Including regular PA as an
adjunct to a weight loss program has also been shown to result in a
disproportionate amount of visceral fat loss (1 89). Furthermore, PA has been
shown to increase as a function of body weight (209), therefore, regular weight
maintenance is recommended for prevention of the metabolic syndrome ( 140).
Similar benefits from performing regular PA have also been observed in
older adults. Favorable effects on body weight, body composition, lean body
mass (LBM), and intra-abdominal adipose tissue have been observed in male
and female master athletes (1 66, 183, 21 4) compared to sedentary age-matched
controls. With losses of one kilogram of muscle per year after .the fifth decade of
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life, PA programs that include resistance training (RT) can help attenuate this
process while preserving function (156).

Physical activity and the metabolic syndrome

The health benefits of regular PA are well recognized (162). A search of
the peer-reviewed literature on the association between PA and the metabolic
syndrome identified 25 studies, 19 cross-sectional studies (31, 32, 37, 54, 56, 78,
80, 87, 90, 105, 114, 132, 143, 144, 150, 161, 187, 217, 233) and six prospective
studies (36, 66, 113, 117, 129, 131). Central to the research and literature
examining the association of PA and the metabolic syndrome is the issue of PA
volume. Frequency, intensity, and duration of PA are the components used to
precisely measure PA volume.
The following section will discuss the 25 studies identified in the literature
examining the association between PA and the metabolic syndrome. Both the
cross-sectional and prospective studies identified in the literature will be _
presented by level of precision in which PA is measured , starting with least
precise and leading to the most sensitive measures of PA. Predominantly, these
studies focused on LTPA and not physical activities from the other PA domains

(i.e., domestic, transportation.)

Muscular strength and the metabolic syndrome
In a study examining · the association of musc�lar strength with the risk of
having the metabolic syndrome (155) , Jurca et al. (114) grouped 8,570 men aged
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20-75 years enrolled in the Aerobic Center Longitudinal Study (ACLS) into
s�rength quartiles based on one-repetition maximal ( 1-RM) efforts on variable
resistance equipment. The 1-RM tests performed to calculate a strength index
were the supine bench press, seated leg-press, and leg-extension. Quartile 1
represented the lowest strength index and served as the referent group. Men in
quartiles 2, 3, and 4 were found to be 38% (OR 0.62; 95% Cl, 0.53-0.72)� 57%
(OR 0.43; 95% Cl, 0.37-0.52), and 67% (OR 0.33; 95% Cl, 0.28-0.40) less likely
to have the metabolic syndrome, respectively after adjusting for age and
smoking. However, after adding maximal treadmill time (which is used as a
surrogate measure of cardiovascular fitness in the ACLS) to the model, this
association was slightly attenuated, leaving only men in the top two quartiles for
strength protected from the metabolic syndrome. This finding is not unusual
given the positive impact cardiorespiratory fitness has on metabolic risk ( 1 , 24,
105, 132, 135).
In a follow-up to a cross-sectional study examining the association
between muscular strength and the metabolic syndrome (11 4), tha same
research group examined the association of muscular strength with incidence of
metabolic syndrome in a longitudinal study (113). Subjects were 3,233 men aged
20-80 years enrolled in the ACLS at the Cooper Clinic in Dallas, Texas from
1980-1989.These men were free from CV disease(s) at baseline. Assessment of
muscular strength and defined strength quartiles have been described previously
(114). Quartile 1 defined the low strength category and served as the referent
group.
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The mean follow-up in this study was 6.7 years (range 0.1-22.0 years). A
total of 480 men developed the metabolic syndrome during this time. Men in
quartile 3 and quartile 4 were found to be 23% and 46%. less likely to develop the
metabolic syndrome compared to men in quartile 1 when controlling for age and
examination date. However, following the addition of smoking status, alcohol
intake, number of metabolic syndrome risk factors at baseline, family history of
diabetes, HTN, and early onset coronary artery disease to the model, this
association was attenuated. Following these adjustments, only men in strength
quartile 4 remained at a decreased risk for developing the metabolic syndrome
OR 0,. 76 (95% Cl , 0.57-0.99). Others have also illustrated the benefits of
resistance training and increases in muscular strength on metabolic risk (38, 55,
92, 99, 102, 206). Muscular fitness appears to add another level of protection
against the metabolic syndrome in men (114) and may help with daily and long
term glycemic control.

Total physical activity time

In the Bogalusa Heart Study (87), self-reported levels of PA in hours and
the risk of having the metabolic syndrome as identified by Reaven (173) was
examined. Two questions assessing the level of PA were asked as part of a
detailed health questionnaire. Anyone who replied "do not work" for the work
related activity question (question 1) was not included in the analysis. Question 2
asked about PA outside of work. Both questions provided responses ranging
. from 1 (inactive to 5 (very active). Questions regarding frequency, intensity, time,
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and type were not part of the questionnaire. Total LTPA status was divided into
quintiles ( 1= inactive; 2=some activity; 3=moderate activity; 4=moderate-vigorous
activity; and 5=vigorous activity) to assess the possible inverse association of
having the metabolic syndrome. Individuals who reported being moderately to
vigorously active were 44% to 69% less likely to have the metabolic syndrome
compared to those who reported being inactive; OR 0.56 (95% Cl, 0.36-0.87) for
moderate, (OR 0.3 1; 95% Cl, 0. 16-0.58) for moderate-vigorous, and OR (0.41;
95% Cl, 0.24-0.7 1) for vigorous. A inverse association was noted between the 3 rd
and 4th quintile, however no further reduction in risk was noted specific to the 5th
quintile.
The association between performing PA and having the metabolic
syndrome was examined in the Coronary Artery Risk in Young Adults (CARDIA)
study (36). The study population was made up of over 4,000 black and white
males and females without the metabolic syndrome. Incidence of metabolic
syndrome was observed at baseline, 7, 10, and 15 years. Regular leisure-time
and occupational . physical activities were assessed by the validated Minnesota
Heart Health Program questionnaire (109). Age-adjusted rate of metabolic
syndrome were reported per 1,000 person years. Subjects who reported PA
levels above the study population mean at all four follow-up examinations were
classified as being regularly active; those with inconsistent measures over time
were considered moderately active.
Over a mean of 13.6 years of follow-up, the metabolic syndrome was
diagnosed in 575 participants (36). The age-adjusted metabolic syndrome rate
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was 1Oper 1,000 person years. This was similar in both genders; however, black
women had the highest overall incidence. Following adjustments for age, race,
gender, weight gain, and PA over time, participants who remained regularly
active were found to be 51 % (OR 0.49; 95% Cl, 0.34-.070) less likely to have the
metabolic syndrome compared to their sedentary counterparts. The addition of
education, baseline BMI , baseline PA, smoking status, drinking status, and
dietary covariates to the model attenuated this association slightly, however it
remained significant (OR 0.65; 95% Cl, 0.76-0.98).
In a NHANES I ll (4 1) study examining the association of LTPA and the
metabolic syndrome, as defined by NCE P, in U.S. adults. DuBose et al. (54)
defined LTPA as a three level categorical variable. PA was assessed by
questionnaire, however, duration of each bout of LTPA was not assessed in
NHANES 1 1 1 , and therefore, -the quantification of LTPA energy expenditure was
not possible. LTPA was categorized into 3 levels: inactive, irregularly active, and
regularly active in order to assess the possible dose-response characteristics of
LTPA. Moderate LTPA was defined as activity ranging from 3-6 METs, and
vigorous activity was defined as > 6 METs. Each activity was then assigned an ·
intensity level· (3). Frequency of LTPA was recorded as days per week (d/wk) and
dividing the number days per month of LTPA by 4.3 weeks. Those completing �
5 d/wk of moderate LTPA and/or � 3 d/wk of vigorous LTPA were considered
regularly active, those who reported some LTPA, however not � 5 d/wk of
moderate or � 3 d/wk vigorous, were considered irregularly active. Participants
who reported no LTPA over -the last 30 days were considered inactive. Irregularly
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active and inactive men were found to be 52% (OR 1 .60; 95% Cl, 1.11-2.31) and
60% (OR 1.52; 95% Cl, 1.18-1.98) more likely to have the metabolic syndrome
compared to regularly active men after adjustment for age, race, gender, and
education. These findings illustrate a protective association for participating in
regular LTPA in men. In contrast, pt,y§ical inactivity was not found to be
associated with the risk of having the metabolic syndrome in women. These
findings were consistent with previous studies examining the level of LTPA and
risk of having the metabolic syndrome in women (1 05, 131, 161).
In the first two years of most recent NHANES (1999-2000) (40), a
nationally representative sample of the noninstitutionalized U. S. population, the
association between sedentary behavior, PA, and the metabolic· syndrome ( 1 55)
was examined (78). 1,626 participants, � 20 years of age,. who reported for a
morning medical examination were included in the study. During this
examination, subjects were asked to report the frequency and duration that they .
spent performing 43 different leisure-time physical activities and any type of
domestic physical activities of moderate or vigorous ·intensities (40), however,
available data on absolute intensities for each activity (METs) were not utilized in
this study. The total PA time in minutes perweek (min/wk) was calculated by
summing the weekly minutes of participation for each activity. A three level
categorical variable was then created: 0 min/wk; < 150 min/wk; and � 1 50
min/wk. Time spent watching TV or playing video games was assessed and a
three level categorical variable was developed for part of the analysis: � 1 hour
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per day (hr/d), 2 to 3 hr/d, and � 4 hr/d; and a five level categorical variable for
another part of the analysis: < 1 hr/d, 2 hr/d, 3 hr/d, and � 4 hr/d.
. In this study, men and women who were physically inactive were found to
be 63% (OR 1.65; 95% Cl, 1 .01-2.65) more likely to have the metabolic
syndrome after controlling for age, than those reporting �-150 min/wk of PA.
However, after adding gender, ethnicity, education, smoking status, - and alcohol
intake to the model this association was attenuated and became non-significant
(OR 1.45; 95% Cl, 0.86-2.44). When stratified by gender, women were over twice
as likely to have the metabolic syndrome when reporting no PA compared to
women reporting � 150 min/wk (OR 2.35; 95% Cl, 1.19-4.63). Physical inactivity
was not associated with the metabolic syndrome in men following stratification.·
Participants reporting watching TV and/or playing video games � 4 hr/d were
found to be twice as likely to have the metabolic syndrome when compared ·to
· those reporting these activities for < 1 hr/d. Following stratification by gender,
women were almost three times as likely to have the metabolic syndrome if they
reported watching TV or playing video games � 4 hr/d when compared to women
reporting < 1 hr/d of these activities. Regardless of their level of TV viewing or
video game playing,· men were not found to be at an increased risk for the . .
metabolic syndrome.
The 1999-2000 AusDiab Study collected data from a national
representative sample of over 11,000 adults in Australia (57). From this
population, 7,821 adults > 35 years of age who had complete data on metabolic
syndrome criteria, television (TV) viewing time, and PA time were enrolled in a
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study to examine the association of time spent watching TV and hours per week
(h/wk) engaging in moderate· or vigorous PA with the likelihood of having the
-- metabolic syndrome (56, 223). Subjects, using a previously validated tool (1 84),
reported total TV viewing time or time spent playing video games over the
previous seven days. A three level categorical was created for TV viewing: 0-7
hours per wk (hr/wk), 7. 1-14 hr/wk, and > 14 hr/wk. The validated Active
Australia Survey Questionnaire ( 10) was utilized to collect data on subjects
frequency and.duration of PA over the previous seven days. This included
activities like walking for exercise or transportation, 'other' moderate activities
and vigorous activity. The total PA time was summed by adding time spent
walking and performing 'other' moderate activities and then adding double the
time spent performing vigorous PA. The 'Active Australia' method takes into
account the higher physical activity energy _expenditure (PAEE) per unit of time
associated with higher intensity PA ( 10).
In this study, men were found to be 64% more likely to have the metabolic
syndrome and women were found to be over two times as likely to have the
metabolic syndrome if they reported watching TV or playing video games > 1 4
hr/wk. However, after controlling·for · age, education, family history of diabetes,
smoking status, and dietary covariates, only women remained at risk. Men and
women reporting participating in � 2.5 hr/wk of total PA were found to be 28%
(OR 0.72 95% Cl, 0.58-0.90) and 47% (OR 0.53; 95% Cl, 0.38-0.74) less likely to
have .the metabolic syndrome, respectively, after controlling for- all confounders.
. Furthermore, women were 38% (OR 0.62; 95% Cl, 0.4 1-0.95) less likely to have
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the metabolic syndrome if they reported walking or 'other' moderate PA and 68%
(OR 0.32; 95% Cl , 0. 13-0. 78) less likely to have the syndrome if they reported �
60 min of vigorous PA per week. Men only received protection from total of � 2.5
hr/wk of PA performed. One explanation for this may be women have been found
to report PA more accurately than men (205). Also, limitations of the
measurement tool, which excluded both domestic and occupational domains of
PA must be considered.

Physical activity energy expenditure (PAEE)
Some investigators have utilized total PAEE when examining potential
associations between PA and the metabolic syndrom·e. Determining the effects of
PAEE on the risk of having the metabolic syndrome (223) is paramount i due to
the fact that it may be_ easier to get people to make small changes in their total
energy expenditure than trying to improve their fitness level (80). In a study
analyzing ·the relationship between habitual energy expenditure, fitness and the
metabolic syndrome, the physical activity level (PAL) was developed to measure
PA (217). The PAL was derived from estimating total kcal energy expenditure
using the HRFlex method (42) and basal metabolic rate (BMR) to examine the
association with the metabolic syndrome as defined by Reaven (173). The
oxygen consumption-heart rate (HR) relationship was assessed at rest (217).
Subjects were asked to come into the laboratory and cycle on an ergometer at 0
watts (YV), 37.5 W, 75 W, and 125 W. Data on HR and oxygen and carbon
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dioxide subfractions were collected. Energy expenditure was designated in
kilojoules per minute (kj/min).
Flex HR, which is the point used to differentiate between inactivity and
exercise was calculated as a mean of the highest resting pulse and the lowest
HR during exercise. Mean resting energy expenditure was calculated and basal
metabolic rate was predicted (82). Cardiorespiratory fitness 0/02 max) was
predicted as oxygen uptake at maximal HR determined from a regression line
during the individual HR calibration. Heart rate monitors were worn for four days
and PAL was derived from subtracting the average energy expenditure at rest,
from total energy expenditure. This was expressed in units of fat free mass
(FFM). PAL was divided into quartiles with the lowest PAL defining the referent
group. Utilizing multiple-logistic regression analysis, the overall association
treating PAL quartile as a ranked categorical variable .for the metabolic syndrome
was 0.64 (95% Cl 0.43-0.94) per quartile. The OR following adjustments for sex
and BMI was 0.62 (95% Cl, 0.42-0.92);
In a cross-sectional study of 874 healthy Caucasian participants from the
Medical Research Council (MRC) Ely Study (216), the association of habitual PA
expressed as PAEE and the likelihood of having the metabolic syndrome was
evaluated (80). In addition, cardiorespiratory fitness levels were obtained to
examine whether PA or fitness provided more protection from the metabolic
syndrome. The HR Flex methodology for this study is described above (217) .
Following adjustments for age, gender and V02 max, the association be.tween
PAEE expressed in kj/kgFFM and the metabolic syndrome were three times
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stronger than the associations for V02 max-pred, These data also illustrate that
those below the mean level of fitness (V02 max-pred) are less likely to have the
metabolic syndrome if they acquired an adeq·uate level of PAEE. With PAEE
divided into quartiles, a clear inverse association was observed for increasing
levels of PAEE and the likelihood of having the metabolic syndrome: Also, these
data suggest that increasing levels of PAEE may be more effective in less fit
individuals.
Ekelund et al. (66), in the MRC Ely Study (217), examined whether PAEE
and aerobic fitness (V02max) predicted the development of the metabolic
syndrome (223) in a group of middle-aged healthy Caucasian men over a 5.6
year time frame. PAEE was measured using the flex heart method described
previously (80) and aerobic fitness (V02max) was predicted by extrapolation and
expressed per unit of FFM (80).
PAEE was divided into quartiles: < 44 kilojoule (- 10.5 kcal) per kg of FFM
per day (kJ/kgFFM/d); 44-70 (- 10.5-17 kcal) kJ/kgFFM/d; 71-100 (-17-24 kcal)
kJ/kgFFM/d; and > 100 (-24 kcal) kJ/kgFFM/d. The PAEE at baseline significantly
predicted progression toward metabolic syndrome at 5.6 years. There was a
significant difference found between the first and second quartile of the PAEE
and the likelihood of having the metabolic syndrome. However, no additional
decrease in risk was observed in other quartiles, thus suggesting a threshold
effect for a PAEE of � 44 kJ/kQFFM/d or 10.5 kcals per every 2.2 pounds of FFM
per day. This association was unchanged after adjusting for level of adiposity as measured by WC or percent body fat. This was the first population-based
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prospective study that used a validated objective measure to examine the
association between PAEE and the metabolic syndrome (80).
The association between LTPA and the likelihood of having the metabolic
syndrome was examined in the CHHS, which is a national representative sample
of Canadian adults surveyed between 1986 and 1992 (3 1). Participants were
classified as physically inactive or active in accordance with their levels of self
reported LTPA. A participant was considered active if they reported performing at
least 30 minutes of LTPA that induced sweating, once a week over the last 30
days. If they did not meet these criteria, they were considered inactive. The
information provided on intensity (sweating) was not enough to determine
whether moderate or vigorous LTPA was performed. Men, but not women who
reported at least 30 minutes of LTPA that induced sweating four times over the
last month were found to be less likely (OR 0.45; 95% Cl , 0.29-0.69) to have the
metabolic syndrome, however, women did not receive the same protection (OR ·
0.67; 95% Cl, 0.44-1.02). However, without information regarding LTPA intensity,
LTPA volume was unable to be determined. Having information on intensity may ·
have helped elucidate why there was no protective association found between
LTPA and the metabolic syndrome in women in this study.

Metabolic equivalents (METs) of physical activity
A more sensitive measure for expressing total volume ·of PA includes
utilizing a measure of absolute intensity expressed in METs. METs are obtained
by dividing the oxygen uptake in mL·kg·1 ·min·1 by 3.5 mL· kg· 1 ·min· 1 ( 100}. This
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can also be expressed in MET·min ·wk-1 ; for example, an individual running 5
times per week at an intensity level of 4 METs for 30 minutes would accumulate
600 METmin·wk-1 of PA:

(5 times/week) * (4 METs) * (30 minutes) =600 MET·min·wk· 1

Recently, physical activity epidemiology studies examining the metabolic
syndrome and the role of PA (105, 129, 131, 144, 177) have been able to utilize
a more sensitive measure of PA by assigning a specific MET level to the activity
performed (3). This allows investigators to more easily quantify self-report PA
data collected by questionnaires and examine potential inverse relationships.
Two studies identified in the literature utilized a PA intensity score (PAIS) .
(161, 233) to define the PA level and examine the association with the metabolic
syndrome utilizing the NCEP definition. PAIS is defined by the ratio of work ·
metabolic rate (METs) to resting metabolic rate (RMR) obtained by a self-report
recall of participation in one or more of the following activities d uring the past
month: walking, jogging or running, cycling, swimming, resistance training,
exercise classes, or yard work (41).- PA was categorized- based on the
participants, PAI S (MET equivalent) over the last 30 days. A PAIS of � 3.5 was
classified as inactive, 3.6 -14.9 was classified as moderately active, and � 15
was classified as active for both men and women. These specific values
· designated the 15th and 65th percentile of PA for men and the 25th and 75th
percentile of PA for women in the US (154).
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In the Third National Health and Nutrition Examination Survey (NHANES
Ill), Park et al. ( 161) utilized the PAIS to define physical inactivity while examining
the relationship of -being inactive with the metabolic syndrome. Individuals with a
PA intensity score � 3.5 were designated physically inactive and identified the
15th and 25th percentiles of adult males and females respectively in the U.S.
population. In a multivariate odds ratio (OR) model adjusting for ethnicity, BMI ,
smoking status, alcohol intake, carbohydrate intake, education level in years,
household income, and menopausal status, neither men (OR 1.4; 95% Cl 1.02.0) or women (OR 1.2, 95% Cl 1.0-1.4) classified as physically inactive by a
PAIS of � 3.5 were found to be at an increased risk for having the metabolic
syndrome. Therefore, suggesting no relationship between physical inactivity and
the metabolic syndrome.
In another study utilizing the same NHANES Ill dataset and PAIS, Zhu et
al. (233) examined the relationship of being active, moderately active, and
inactive based on a PAIS � 15.0 (active), �3.6 to 14.9 (moderately active), and
�3.5 respectively, with the likelihood of having the metabolic syndrome. Both
males (OR, 0.41 95% Cl 0.3 1-0. 54) and females (OR, 0.25, 95% Cl 0. 18-0.37) in
the active group were found to b_e ·less likely to · have the metabolic syndrome
compared to the inactive group. Following adjustments for BMI , males were 73%
less likely (OR 0.27, 95% Cl, 0. 18-0.40) and females were 68% less likely (OR
0.32; 95% Cl, 0.2 1-0.51) to have the metabolic syndrome if they reported being
active. In men and women who reported being moderately active they were.
found to be 34% less likely (OR 0.66; 95% Cl, ·0.48-0.89) and 3 1 % · less likely
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(OR 0.69; 95% Cl, 0.48-0.99) to have the metabolic syndrome respectively.
These findings illustrate a potential inverse association between PA and the
metabolic syndrome. However among females, after adding age, race,
education, income, and menopausal status to the model, the protective effect of
PA disappeared.
In a cross-sectional sample of 711 white males, Carroll et al. (37) utilized a
leisure-time physical activity index (PAI) ( 192) to examine the association
between LTPA and the metabolic syndrome using the criteria originally put forth
by Reaven ( 173). Data from a 4-week history of L TPA was available for 697 of
the original 7 11 men. These men were asked about their usual LTPA patterns,
designating regular walking in minutes per weekday (min/wkd), cycling activity in
minutes per day (min/d), recreational activity in hours per weekend (h/weekend),
and vigorous activity in times per month (times/m). A PAI score was calculated
based on frequency, _ duration, and intensity of each activity. Scores were
assigned for each mode of activity and time spent performing the activity based
on the intensity and energy requirement of each activity reported (202, 230).
These men were grouped into four categories: inactive (0-2 consisting of no
LTPA); occasional/light (3-8 consisting of walking and some more vigorous
activities); moderate/moderate vigorous (9-20 consisting of cycling or frequent
sporting activities); and vigorous (� 21 consisting of very frequent sporting and
recreational activities.)
When compared to the inactive group, men with a PAI of 3-8 were found
to be 44% less likely (OR 0.56; 95% Cl, 0.33-0.96) to have the metabolic
54

syndrome. This would equate to performing LTPA 2-3 times per week at 3-4 MET
level for 30-40 minutes per session, or approximately 300 MET·minwk·1 • Men
with a PAI of 9-20 were found to be 67% less likely (OR 0.37 95% Cl, 0.1 9-0.7 1 )
to have the metabolic syndrome. This would equate to performing LTPA 3-4
times per week at a 5-6 MET level for 30-45 minutes per session, or
approximately 700 MET·min·wk-1 . Men with a PAI � 2 1 were found to be 88%
less likely (OR 0. 1 2; 95% Cl, 0.03-0.50) to have the metabolic syndrome and this
would equate to performing LTPA 4-5 times per week at � a 6.5 MET level for 4560 minutes per session, or approximately 1 530 MET·min·w1<· 1 . A clear inverse
association was noted for each increase in PAI score.
Misra et al. (1 50) reported the association between LTPA and the
metabolic syndrome in a study of Asian Indian immigrants living in Northern
California. In this study, LTPA was expressed as a score of activity metabolic
index (AMI) utilizing a Taylor intensity code (202) reported for each type of LTPA
performed over the last 1 2 months. When examining the risk of metabolic
syndrome as defined by NCEP, an AMI was calculated for light, moderate,
heavy, and total L TPA over the last year:

Total AMI =

I:

(intensity*months/year) * (frequency/month) *
(time/session)

This study found that compared to women, men were twice as likely to be
active. Also, men and women with the metabolic syndrome reported the lowest
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levels of LTPA estimated by the AMI . Men engaging in moderate LTPA of
approximately 88 MET·min·wk·1 and high intensity PA of approximately 180
MET·min·wk·1 for a total of 268 METmin·wk·1 were found to be significantly less
likely to have the metabolic syndrome than men performing only light LTPA. This
association was not seen in women. Women reported performing activities of
similar intensity to men; however the total number of MET·min·wk· 1 of LTPA
performed by women was less than half of that performed by men. Women
reported engaging in approximately 203 METmin·wk- 1 of PA or 50 total minutes
of LTPA per week, while men reported engaging in approximately 533
MET·min·wk·1 of accumulated LTPA or 124 total minutes of LTPA. This
illustrated an inverse association between PA and the risk of being diagnosed
with the metabolic syndrome.
In a study of Aboriginal (native) Canadians examining non-traditional
cardiovascular risk factors and their association with the metabolic syndrome as
defined by three different medical societies (103, 155, 223), the association of PA
with the syndrome was also evaluated (144). The lifestyle for Aboriginal people
traditionally involved activities of daily living (ADLs) being of the vigorous nature,
however, over the last 20 years many Aboriginals have drastically reduced - their
daily PA levels. Data was collected on 360 non-diabetic adults participating in a
study of Aboriginal Canadians. A previously modified PA questionnaire (125) was
used to assess PA. Participant PA levels were determined by LTPA and
occupational activities over the past 12 months. Activity intensity was esti_mated
so PA could be expressed in MET hours per week (MET·h/wk·1 ). In addition,
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cardiorespiratory fitness level was estimated utilizing a validated step protocol
(193) and expressed in mL·kg-1 · min-1 .
In a multiple logistic regression model controlling for age, percent body fat,
smoking status, and fitness level, men who reported engaging in regular PA were
found to be 4% less likely to have the metabolic syndrome, (OR 0.96; 95% Cl,
0.93-0.99) for every 5 METh/wk- 1 increase in PA. This relationship not observed
in women (OR 1.00; 95% Cl, 0.98-1.03). However, in the same model with the
substitution of PA level for CV fitness, men and women were found to be 84%
and 66% respectively, less likely to have the metabolic syndrome for every 1O
ml·kg- 1 · min-1 increase in cardiorespiratory fitness. The stronger association for
fitness over PA is difficult to explain, but is most likely due to the objective nature
in which cardiorespiratory fitness was measured compared to the self-report
assessment of PA (23). In addition to utilizing the WHO (223) definition, these
investigators when applying the NCEP (155) and IDF ( 103) definitions did not
detect any changes in the results.
· In a national study of over 50,000 Chinese, aged 15- 96, the association
between low, moderate, and high levels of PA performed at varying intensities
and the risk of having the metabolic syndrome as defined by the Chinese Medical
Association was examined ( 143). Following adjustments for gender, age,
smoking status, alcohol intake, and BMI, those who reported performing 900
MET min·wk-1 of low-level PA for were found to 55% less likely to have the
metabolic syndrome when compared to those who reported performing 450
MET·min·wk- 1 of low-level PA. In addition, Chinese men and women who
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reported engaging in � 360 MET-min-wk- 1 of vigorous PA were found to be 25%
less likely to have the metabolic syndrome than those reporting < 360
MET-min·wk·1 of vigorous PA.
The association between MET hours per week (MET·hr·wk-1 ) of LTPA and
the likelihood of having the metabolic syndrome was examined in the Whitehall I I
study of civil servants aged 45-68 years (177). The metabolic syndrome was
defined as meeting the cut-off points for the sex-specific top quintile, or bottom
quintile in the case of HDL-C for three or more of the following: post-glucose
load; SBP; fasting triglycerides; fasting HDL-C; and waist to hip ratio. This was
done due to the fact that no medical society definition for the metabolic syndrome
had yet been published; and these quintile cut points were thought to
representative of a level of increased risk for CVD. Utilizing a modified version
the Minnesota leisure-time physical activity questionnaire (202), data on 20
different activities were collected. Activity patterns over the last month were
ascertained in order to get a notion for habitual activity. Activities were assigned
a MET value (3) to calculate MET hours per week (MET·h/wk· 1 ). MET values for
activities were grouped into two categories: moderate (METs � 3 to < 5 METs),
this included walking and yard work, and vigorous (METs � 5). Moderate activity
was then divided into two categories consisting of < 24 MET·h/wk-1 and � 24
MET-h/wk-1 . Vigorous activity was divided into four categories: no vigorous LTPA,
< 5 MET h/wk-1 ,

�

5 and < 12.5 MET-h/wk-1 , or � 12.5 MET·h/wk- 1 .

Following adjustment for age, gender, smoking status, .alcohol .intake, and_
job grade (grade 1 represented the highest job.status and grade 6 represented
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the lowest job status), individuals reporting � 24 MET·h/wk-1 of moderate LTPA
were found to be 22% less likely (OR 0.78; 95% Cl, 0.63-0.96) to have the
metabolic syndrome when compared to those reporting < 24 MET·h/wk- 1 of
LTPA. Those who reported performing some vigorous L TPA, but accumulated <
5 MET·hr·wk·1 were found to be 3 1% less likely (OR 0.69; 95% Cl, 0.52-0. 91) to
have the metabolic syndrome, while those reporting � 5 METs, but < 12.5 METs
of vigorous LTPA were found to be 23% less likely (OR 0.77; 95% Cl, 0.60-0.99),
and those who reported engaging in � 12.5 MET·hr·wk- 1 of vigorous LTPA were
found to be 48% less likely (OR 0.52; 95% Cl, 0.40-0.67) to-have the metabolic
syndrome compared to those reporting no vigorous activity LTPA.
In a study of 107 middle-aged men participating. in the KIHO Study, LTPA
and the development of the metabolic syndrome as defined by the WHO was
examined (13 1). The inclusion of microalbuminuria in the WHO definition as a
component of the metabolic syndrome had been challenged· ( 14,· 110); therefore it was excluded from the analysis. The KIHD 12 month LTPA Questionnaire (134)
was utilized to assess the duration, frequency, and average intensity of the most
commonly performed physical activities. Low LTPA was defined as < 4.5 METs,
moderate LTPA was defined as � 4.5 METs, and the cut-off point for vigorous
LTPA was � 7 .5 METs. The total time in minutes per week (min·wk) for these
three levels of LTPA was summed. The odds risk ratios for total L TPA, low
intensity LTPA, moderate and vigorous LTPA, and vigorous LTPA and the
likelihood of having the meta�olic syndrome were calculated.
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At the 4-year follow-up, and adjusting for age and BM I , men reporting
engaging in a total amount of LTPA � 487 min ·wk· 1 were found to be 47% less
likely (OR 0.53; 95% C l , 0 . 3 1 -0 .92) to have the metabolic syndrome compared to
men reporting < 270 min ·wk· 1 (referent g roup) . In the same model, similar
reductions in risk were observed in men reporting � 1 80· min·wk· 1 or
approximately 720 MET·min ·wk· 1 of moderate (OR 0 . 52; 95% C l , 0. 30-0. 90) and
vigorous (OR 0.37; 95%C I , 0 . 2 1 -0 .66) LTPA. For vigorous activity, men reporting
a total of � 60 min·wk· 1 or 450 MET-min·wk-1 of LTPA were found to be 64% (OR
0.36; 95% C l , 0. 1 9-0.70) less likely to have the metabolic synd rome compared to
men reporting < 1 0 min ·wk- 1 of vigorous activity (referent g roup) . No association
between moderate LTPA and metabolic synd rome was observed . This was the
first longitud inal study reporting the association of LTPA with the development of
the metabolic synd rome (1 3 1 ).
1
· 1n another study utilizing the measure of MET·min·wk· of LTPA, the same

group ( 1 3 1 ) exam ined the association between vigorous LTPA and the
development of the metabolic syndrome (223) among low birth weight men (1 29) .
Data on birth weight and length was gathered on 462 men aged 42, 48, 54, or 60
years_ at baseline, in the previously described KI H D Study ( 1 85) . The researchers
used the ponderal index (Pl) which was computed as birth weig ht in kg/length
(m 3) (1 80). The assessment of LTPA and the classification of the vigorous LTPA
were described previously ( 1 3 1 ).
Men who were underweight at birth according to the Pl were two times
more likely (OR 1 .98; 95% C l , 1 . 09-3.60) to have the metabolic syndrome than
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men with a normal Pl_. However, the risk of having the metabolic syndrome
among low-birth weight men was nullified in those reporting � 25 niin·wk·1 or 188
MET·min.wk·1 of vigorous LTPA when compared to men reporting < 25 min·wk· 1
or 188 MET·min.wk·1 of vigorous LTPA. This association remained following
adjustments for child or adult socioeconomic status (SES) and BMI. These
results illustrate that an active lifestyle can modify health outcomes in what some
consider a thrifty phenotype (17, 98). Individuals with a thrifty phenotype have a
smaller body size and lower RMRs, thus making them more susceptible to
metabolic disorders, particularly in affluent societies ( 16).
Physical activity and the risk of the metabolic syndrome as defined by
NCEP was examined in a sample of tri-ethnic females ( 105). This study had 146 .
subjects who were enrolled in the Cross-Cultural Activity Participation Study (4,
106). The Cross-Cultural Activity Participation Study is a study designed to
examine PA patterns of women > 40 years of age- of varying race and-ethnic
backgrounds. A total of 51 white women, 49 African-American wonien, and 46
Native-American women participated with PA records obtained two times, 30
days apart. Each activity had the type, duration, and intensity recorded and wa�
used to calculate MET minutes per day (MET-min/d-1 ) for moderate and vigorous
LTPA. Utilizing the compendium of physical activities (3), each. activity had a ·
MET value assigned to it. This allowed the absolute intensity of the LTPA to be
measured. Women reporting 491 MET·min/d-1 to 1351 MET·min/d- 1 of moderate
intensity LTPA were found to be 82% (OR 0.18 ; 95% Cl, 0.03-0.90) less likely to
have the metabolic syndrome than women in the least active group. Women
61

reporting any vigorous LTPA were also less likely to have the metabolic
syndrome compared fo their inactive counterparts; however, due to a power
issue related to the inverse association observed with vigorous LTPA, this did not
reach significance.
In the Kuopio tschemic Heart Disease Study (1 32) (KIHD) a cross
sectional association of self-reported LTPA and the risk of having the metabolic
syndrome as defined by the WHO (223) was examined. The KIHD included
1 ,069 middle-aged men free of diabetes and CVD at baseline. The validated
KIHD 12-month LTPA questionnaire assessed the duration, frequency, and mean
intensity of LTPA over the previous year. LTPA was defined as low-intensity
which corresponded to < 4.5 metabolic equivalents (METs), and at least
moderate intensity, which was defined as � 4.5 METs. Three Categories of LTPA
were then created with tertiles of LTPA in minutes per -week (min/wk) in each
category: total minutes of LTPA, MET·min,wk· 1 · of low-intensity LTPA, and
· MET·min·wk· 1 of moderate and vigorous LTPA. - After adjusting for age, men reporting < 2 17 mi11/wk·1 of total LTPA were·
found to· be 64% more likely (OR 1 .64; 95% Cl, 1 �oB-2.49) to have the metabolic
syndrome than men reporting � 409 min/wk· 1 of total LTEA . Low-intensity LTPA
was not found to be associated with the metabolic syndrome. However, men
reporting < 360 MET·min·wk- 1 of at least moderate and vigorous LTPA were
found to have a similar increase in risk for having the metabolic syndrome as
men reporting < 2 1 7 min/wk·1 of total LTPA (OR 1 .63; 95% · CI, 1 . 07-2.48). Thus,
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men reporting engaging in low-levels of LTPA, regardless of the intensity level,
were found to be at an increased risk for having the metabolic syndrome.
In a sample from the HERITAGE Family Study (117), the efficacy of a 20
week aerobic exercise training program was evaluated for treating the metabolic
syndrome (117, 155). There were 621- black and white participants, aged 17 to
65 years, who met the inclusion criteria of being healthy and sedentary adults
with BP < 160/100 mmHg. The metabolic syndrome prevalence was calculated at
baseline and at the end of the 20 week exercise program. Participants began
exercising three times per week, 30 minutes per session at 55% of their V02 max,
or approximately 360 MET·min·wk-1 for the first two weeks and eventually
progressed in the 20 week program to exercising three times per week for 30
minutes at 75% V0 2 m ax , or approximately 550 METmin·wk- 1 . Following baseline
analysis, 105 of the 62 1 participants were found to have the metabolic syndrome,
thus the prevalence was 16.9% for the entire study sampla The prevalence of ·
the metabolic syndrome was similar for black men, white men, and black women,
however, white women were found to have a lower prevalence.
Following the 20 week exercise program, 32 of the 105 participants
classified with the metabolic syndrome at baseline no longer had the syndrome.
In addition, there were no differences between the 32 participants who no · longer
had the metabolic syndrome and the remaining 73 participants who still had the
syndrome in terms of age or current fitness level. Consequently, the prevalence
in this study sample dropped from 1 6.9% to 11.8%. This was the first study to
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report the usefulness of regular PA in the simultaneous improvements of the
constellation of risk factors that make up the metabolic syndrome.
Santos et al. (187) evaluated the association between PA, hours spent
sleeping, alcohol and smoking habits with the risk of the metabolic syndrome.
Self-report data was collected on 2, 164 adults ( 1,332 women; 832 men), · aged
18-92 years. PA data was collected from occupational (included transport to· and
from work), domestic and LTPA domains over the previous 12 months. A MET
level was assigned to each group of activities and these groups were categorized
as very light, light, moderate and heavy activities with the corresponding mean
MET values of 1.5, 2.5, 5.0 and 7.0 respectively. MET values were then
multiplied by the duration of each activity in minutes per day. Participants MET
hours per day (MET/h/d) were then divided into tertiles for all three domains of
PA and total PA.
Following adjustment for age, education, smoking, and alcohol intake
women in the upper tertile of total PA (1.54-3.46 MET/h/d) were found to 37%
less likely (OR 0.63; 95% Cl, 0.43-0 .94) and men in the upper tertile of total PA
( 1. 59-4.29 MET/h/d) were found to be 45% (OR 0. 55; 95% Cl, 0.33-0.91) less · .
likely to be diagnosed with the metabolic syndrome compared those in the lowest
tertile. When examining the other three PA domains individually, there was no
association found in men for occupational, domestic, or LTPA with the metabolic
syndrome. However, women received the same level of protection from upper
tertile of occupational PA (OR 0.63; 95% Cl, 0.40-0.99) as they did from the

64

upper tertile of total PA (OR 0.63; 95% Cl, 0.43-0.94). There was no association
found in women for domestic or LTPA with the metabolic syndrome.
These results suggest that LTPA by itself may not be sufficient in reducing
the risk of being diagnosed with the metabolic syndrome. Total PA accumulated
from all domains may be more important -in attenuating metabolic syndrome risk.
Also, women with physically active jobs may receive protection from the
metabolic syndrome.
The association between regular PA and the risk metabolic syndrome has
also been examined in older adults (90). In a cross-sectional study examining PA
and its association with the metabolic syndrome as defined by NCEP, over 4,000
men and women, 60 years of age and older were surveyed. PA over the past 12
months was categorized into four groups: 1) Low PA of < 240 MET· min·wk·1
representing a sedentary lifestyle; 2) Light PA (�240 MET·min·wk· 1 , generally
without sweating, although not a good marker for PA intensity (219)); 3)
moderate PA (approximately 360 MET-min·wk·1 , regularly active one to two times
per week for at least 30 minutes per session); and 4) High PA (�360
MET·min·wk-1 . ) The results of this study indicated an inverse association
between regular PA and the metabolic syndrome. Compared to group 1 (< 240
MET-min·wk·1), participants reporting at least 240 MET-min·wk·1 (group 2) of PA
were found to be 50% less likely (OR 0.50; 95% Cl, 0.40-0.64) to have the
metabolic syndrome. Those reporting at least 360 MET;min·wk·1 (group 3) were
found to be 57% less likely (OR 0.43; 95% Cl, 0.32-0.58), and those reporting �
360 MET·min·wk- 1 were found to be 67% less likely (OR 0.33 ; 95% Cl, 0.22-0.51)
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to have the metabolic syndrome. Hence, a clear inverse association between PA
and the metabolic syndrome was seen in this study of older adults.·

Summary of physical activity and the metabolic syndrome literature
In the literature, there is a consistent inverse association found between participation in regular PA and the likelihood of having the metabolic syndrome.
An inverse association between PA and the likelihood of having or developing
the metabolic syndrome was observed in more than half the studies cited in this
-

review. Physically active study participants were found to be 4% to73% less likely
to have the metabolic syndrome compared to their inactive peers. This
association is influenced by the study population, study design, and how PA is
measured. The minimum effective dose is not well defined, but. a total of � 150
m1n·wk of moderate PA or � 60 -min·wk-1 of vigorous PA appears to be associated
with a reduced risk of having or developing the metabolic syndrome. When
examining absolute volume of PA with metabolic syndrome risk, protection
appears· to start at approximately 300 MET-min·wk- 1 , which could be
accomplished by taking a 30 min walk at a moderate intensity (3-4 METs) three
of four times pef week.
There were many limitations reported in these studies. The lack of data on
frequency, duration, intensity, and mode of PA was not available in many studies,
thus excluding a true absolute measure of PA volume from being utilized. The
self-report nature of survey (questionnaire) data is subject to recall bias. The PA
questions in most of these studies focused on LTPA only. Some questionnaires
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utilized in these studies have not been validated. Three-quarters of the studies
identified were of the cross-sectional nature, · thus causality is unable to be
established. To date, there have only been two studies examining muscular
strength and the risk of the metabolic syndrome, and they were both in men. .

Future physical activity and metabolic syndrome research needs
Studies of PA and metabolic syndrome risk should focus on the strength
of the inverse association. It has been established that approximately 30 minutes
of moderate activity on most days of the week or approximately 60 min of
vigorous activity performed at least 3 days per week will reduce the risk of the
metabolic syndrome. Furthermore, some-studies appear to show different
associations for PA and metabolic syndrome risk between genders. Future
studies are needed to examine the association disparity between genders.
Furthermore, the effects of resistance training (i.e., muscular strength) on
metabolic syndrome risk, warrant co·ntinued investigation in men and need to be
evaluated in women.

Summary
The current prevalence estimates of the metabolic syndrome around the
world range from a low of 7.8% -(7) to a high of 39.1% (75). These prevalence
estimates vary depending . on the population being studied and the metabolic .
syndrome definition utilized. Prevalence appears to greater in nien and increases
with age. The greatest impact on metabolic syndrome prevalence is the medical
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society definition applied to a study population. Several studies have utilized
various definitions of the metabolic syndrome, thus making it difficult to make
comparisons between studies. The core components (glucose, obesity,
dyslipidemia, and HTN) are similar in all the commonly utilized working
definitions (46, 85); however, the cut-off points for each condition are not
consistent among definitions. With comparison of two different definitions in the
same population, prevalence estimates of the metabolic syndrome have been
shown to differ (75, 76), thus definition utilized has been shown to have an
impact on prevalence.
In all 25 studies identified in the literature that have examined the
association of PA with the metabolic syndrome, a consistent inverse association
or suggestion of potential protection was found between participating in regular
PA and the likelihood of having or developing the metabolic syndrome. Some of
these studies found the favorable effects of PA to be limited to a specific gender
(54, 78). However, in the majority of the studies that included both men and
women, some level of protection from being physically :active was observed.
Overall, it appears as the volume of PA increases, the likelihood of having or
developing the metabolic syndrome decreases. The precise amount of PA
necessary to elicit a reduced risk of the metabolic syndrome is not well defined,
however, current research illustrates that meeting the recent public health
recommendation for PA (162) would be prudent.
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The . purpose of this study was to examine the relationship between
Leisure-Time Physical Activity (LTPA) and the likelihood of having the Metabolic
Syndrome in a nationally representative sample of the United States (U.S.) adult
population. The following section furnishes a detailed description of the
methodology that was utilized in this study. The study employed secondary data
analysis of the most recent release of the 1999-2004 National Health and
Nutrition Examination Survey (NHANES). This section includes a discussion of
the subjects, a description of NHANES 1999-2004, variables of interest, and data
analysis.

Subiects

The subjects included in this study participated in the 1999-2004 NHANES
(6). NHANES is conducted by the National Center for Health Statistics (NCHS)
and is a continuous survey that regularly releases public use data as smaller ·
component-specific files (3). The most recent survey was conducted from 1999
through 2004 and represents the eighth series of NHANES. The total sample N
for the most recent six years of data released from NHANES was 3 1, 126 and
included individuals two months of age and above. The final sample for this study
was 5,620 U.S. aduits � 20 years of age who were given a clinical exam following
an overnight fast (minimum 8 hours).
The sample for this study met the following conditions: 1) adult men and
women � 20 years of age; 2) attending a morning MEC examination following a�
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overnight fast; 3) if a women, not pregnant; and 4) had provided complete data
on all the variables· of interest.

Data Col lection

Data were collected from a nationally representative sample of U. S.
adults, � 20 years of age (N= 31,126) living in residences that were selected in
NHANES 1999-2004. All eligible study participants, o-r their guardians, were
provided with and signed an informed consent describing the details of the
survey. All information collected was kept confidential in accordance with the
· Public Health Service Act and the Privacy Act of 1974 (15). The main objectives
of NHANES are to estimate the prevalence of various diseases and risk factors in
the U.S. population in order to monitor trends for treatment and control (6).
NHANES also provides information on risk factors for known diseases in order to
study the relationship between behavior, environment, and health.
The NHANES studies are conducted by the NCHS, which is-a federal
agency that collects health data for the U.S. (3). The NHANES survey design is a
stratified, multistage probability sample of the noninstitutionalized U . S. civilian .
population over the age of two months. The stages of the sample selection
include the following: 1) primary sampling unit (PSU) selection; 2) selection of
PSUs in each segment; 3) selection of residence in each PSU; and 4)
interviewing at least one person in each household. The 1999-2004 NHANES
over-sampled low-income persons, adolescents , persons 60 years of age and
older, and minorities (3). Previously, NHANES were conducted on a periodic
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basis and data were released in single data set covering multiple years . .
Beginning in 1999, NHANES has been conducted as a continuous survey,
releasing public use data continuously as smaller component-specific data in
two-year phases. For example, NHANES 1999-2004 data were released as
NHANES 1999-2000, NHANES 2001-2002, and NHANES 2003-2004.
Each year nearly 7,000 people are interviewed by trained interviewers in
the participants' place of residence. Approximately 5,000 of the people
interviewed in their homes also complete a health examination survey conducted
in a mobile examination center (MEC). If an individual is unable to attend the
MEC , they may receive a health examination at home (6). All interviews are
recorded using a computer assisted personal interview (CAPI) system. Eligible
participants who are 16 years of age or older are interviewed without a guardian,
but those participating in the survey under the age of 16 are interviewed with ·a
parent or guardian (5). These health surveys include questions regarding a wide
breadth of health and nutrition related issues (e. g., has you doctor ever told you
that you have diabetes?).
Participants, who attend the MEC for the health e�amination component,
are examined by a wide range of health professionals. Each MEC team is made
up of one doctor, one dentist, two dietary personal, three certified medical
technologists, five health technicians, one phlebotomist, two trained interviewers,
and a data manager (6). Standardized medical examinations are completed
including measurements directly associated with the metabolic syndrome and
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PA. These measures include blood pressure, lipoprotein values, glucose levels,
waist circumference, and urinanalyis.

Measures
Dependent measure(s}: The Metabolic Syndrome
The dependent variable · in this study was a positive diagnosis of the
metabolic syndrome based on the American Heart Association and the National
Heart, Lung, and Blood Institute (AHA/NHLBI) criteria (9). In 2005, the American
Heart Association and the National Heart, Lung and Blood Institute issued a new
definition which serves as an updated version of the NCEP criteria (9). The
majority of research that has been done on the metabolic syndrome and PA has
involved the use of the NCEP (14) criteria, which preceded the AHA/NHLBI
definition.
The AHA/NHLBI definition requires that three of the following five risk
factors be present for a diagnosis of the metabolic syndrome: 1) impaired fasting
glucose (I FG) � 100 milligrams per deciliter (mg/dl) or undergoing
pharmacological treatment; 2) low high-density lipoprotein cholesterol (HDL-C) <
40 mg/dl in men or < 50 mg/d l in women, or undergoing pharmacological
treatment; 3) triglycerides � 150 mg/dl or undergoing pharmacological treatment;
4) a waist circumference 0/VC) > 102 centimeters in men or > 88 cm in women;
and, 5) blood pressure � 130/85 mm/Hg or undergoing pharmacological
treatment for hypertension (HTN). The AHA/NHLBI definition is unique in the
respect that it precludes specific inclusion criteria of any one condition (e.g., IFG)
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in order for metabolic syndrome to be diagnosed. This most recent definition put
forth by the AHA and NHLB I mirrors the NCEP definition with the following
modifications: _pharmacological treatment for those with dyslipidemia, HTN, and
IFG are positively identified to the respective criteria for diagnosis. In addition,
the cut-off point for IFG was lowered from 1 10 mg/dl to- 100 mg/dl to reflect the
recent changes issued by the American Diabetes Association (ADA) for IFG (1).
A comparison of this definition to other metabolic syndrome medical society
definitions can be found in Table A-1 in Appendix A.
In creating a dependent variable based on a positive diagnosis of the
metabolic syndrome utilizing the AHA/NHLBI definition (METyes), data on blood
pressure, fasting glucose, lipoprotein values, and WC measurements were·
utilized from the MEC related data from the health examination component of the
survey. Each criterion was dichotomized with the demarcation being the cut-off
value for inclusion as a component of the metabolic ·syndrome. For example, the
following is a recode for -blood pressure (BP) that was utilized in our- study:

If 130< = bpxsar or 85< =bpxdar or bpq050a= 1 then AHAHTN= 1 ;·_
else if bpxsar< 130 and bpxdar<85 or bpq050a=2 then AHAHTN= O; .

If a person was found to have a systolic BP (code=bpxsar in NHANES data file) �
130 or a diastolic B P (code=bpxdar in NHANES data file) � 85 or undergoing
. pharmacological -treatment for HTN (code=bpq050a in NHANES data file) they
were coded a 1 for having HTN.
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Metabolic syndrome risk score (MSRS):
In creating a dependent variable based on a positive diagnosis of the
Mets utilizing the AHA/NHLBI definition, data on blood pressure, fasting glucose,
lipoprotein values, and WC measurements were utilized from health examination
component of the NHANES. Each CV risk factor was dichotomized with the
demarcation being the cut-off value or pharmalogical treatment for inclusion as a
component of the Mets (O= no risk; 1= risk). Risk factors were summed and a
total metabolic syndrome risk score (MSRS) was calculated which ranged from 0
(no risk factors) to five (all five risk factors present). Those subjects with a score
of 0-2 risk factors were determined not to have the Mets and those respondents
with a score of 3 to 5 risk factors were determined to have the Mets.

Independent measures
A variety of variables were utilized as independent factors in this study.
The primary independent measure of in this study was LTPA. All other
independent measures were treated as controlling measures.
Leisure-Time Physical activity {LTPA}: Data utilized to measure PA were
collected from two distinct NHANES files. The PA and physical fitness file
, . (PAQ_C) and the PA individual activities file (PAQIAF) from the household
·questionnaire and MEC interview (4). The PAQ IAF is the second of two files on
PA and includes more detailed information regarding 43-specific types of
moderate and vigorous leisure-time activities. This study utilized LTPA data from
the PAQ IAF. The following codes were used to identify the characteristics of PA:
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+ PADACTIV: Numeric code for specific type of PA reported.
+ PADTIMES: Frequency reported for the activity over the past 30 days.
+ PADDURAT: Average amount of time (in minutes) spent during each
activity session.
+ PADIVlETS: Metabolic equivalent (MET) score assigned to each activity
utilizing the compendium of physical activities (2).
The information from the PAQIAF allowed us to create a sensitive measure of PA
to examine the relationship with the metabolic syndrome. Taking the number of
times an activity was done over the last 30 days and calculating how many times
per week the activity was performed provided a frequency per week. Utilizing the
compendium of PA and assigning the appropriate MET level to the type of
activity performed provided us with the intensity of .the specific activ�ty. METs
represents the oxygen uptake for that activity in m�·kg-1 · rnin· 1 divided by 3.5
ml·kg-1 ·min·1 (10). Then, taking the average duration (minutes per session) , the
average frequency (number of sessions per week) and the intensity level (MET
level) assigned to the activity, we calculated MET minute.s per week
(MET·min·wk·1 ). This was done for each LTPA performed._ The sum of all
MET·min·wk·1 performed produced a total MET·min·wk- 1 " measure. The
11

following is an example E>f a calculated LTPA MET·min·wk·1 value from an earlier--
pilot study that examined the relationship of LTPA with the metabolic syndrome
according to the NCEP definition (See Appendix B):
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Frequency (5 sessions per week) x Intensity (4 METs) x (Duration 30 minutes/session)
= 600 MET·min -wk·

1

In order to e�amine a possi�le inverse as�ociatipn for LTP� and the
metabolic syndrome, MET·min·wk·1 was divided into a six-level ordinal variable .
..,. _

The first level represented those wh� were physically inactive, the referent group
for this study. This level included all individuals who reported no moderate or
vigorous LTPA. Thus, they were assigned a score of "O" MET·min·wk·1 . In
calculating the remaining five levels of this measure, the Met·min·wk·1 was
divided into quintiles from the METmin·wk·1 measure. This was done for two
reasons: 1) to accou_nt for the non-normally distributed and skewed_ data that is
inherent to national population surveys (11), and 2) to provide a greater level of
precision when looking for a potential inverse association.
� s�cond measure used focused on whether this possible inverse
association transfers over to a three-level categorical variable based on the
Centers for Disease Control and Prevention and the American College of Sports
Medicine (CDC/ACSM) public health recommendation ( 18). Individuals who
were found to meet the CDC/ACSM PA recommendation of five days per week of
moderat� intensity LTPA for 30 minutes, or three days per week of viggrous
intensity LTPA far 20 minutes were classified as meeting the public health·
recommendation; individuals who were found to engage in LTPA at least one
Jime per w��� but no! meeting the CDC/ACSM recommenda_tion were classified
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in the some, but insufficient category. Those who reported performing no LTPA
were classified as inactive.

Other independent measures
Additional factors that were controlled for included- five demographic
variables; age, race/ethnicity, and two markers of socioeconomic status (SES),
education and income.

Age was categorized into seven, 10-year age-groups: 20-29, 30-39, 4049, 50-59, 60-69, 70-79, and � 80. The division of age into 10-year age-groups
allowed testing for a more precise possible inverse association of PA.

Education
Education was divided into three categories.- Completing less than 1 ih
grade (referent group), completing 12th grade, or education beyond 1ih grade.

Income
Income was categorized as percent of poverty thresholds (< 100% , 100%
to 199%, 200% to 299%, 300% to 399%, > 400%). The standardized poverty
threshold represents dollar amounts that define poverty status while accounting
for family size
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(www.census.gov/hhes/www/poverty.html). Falling below a poverty threshold of
100% demarcates living in poverty.
Further adjustments were made for alcohol consumption, smoking status,
and family history of chronic disease, including heart disease and diabetes. All of
these preceding variables may impact the cardiovascular disease risk factors that
define the metabolic syndrome, and will be briefly discussed below.

Alcohol intake
Alcohol intake in moderation has been shown to have favorable effects in ·
people with the metabolic syndrome (8). In NHANES, alcohol intake is assessed
over the previous 12 months. Moderate alcohol intake is classified as one drink . ·
or less per day in women, and two drinks or less per day in men. In this study, a
three level categorical variable was created; 1) above moderation drinker, 2)
moderate drinker, and 3) non.;.drinker.

Smoking
Smoking is a primary risk factor for coronary heart disease (16, 21),
however, the effects of smoking on the metabolic syndrome-are equivocal (13,
17). In this study, smoking status was divided into three categories: 1) current
smoker, 2) previous smoker, and 3) non-smoker. The three categories allow a
more precise examination of the potential effects of smoking versus using a
dichotomized variable.
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Family history of chronic diseases
Family history of chronic diseases included two conditions; heart disease
and diabetes. The initial definition put forth by NCEP (14) and the updated
AHA/NHLBI (9) definition were created to help identify thos� at high-risk for these
two conditions. For a subject to be classified with a positive family history for · ·
heart disease or diabetes, he/she must have reported that either a parent and/or
sibling have had the condition. These two variables were dichotomized, family
history yes/family history no.

Data Analysis

Weighting
A variety of procedures were used to prepare the data for analysis. This
section discusses data preparation, data management, and recoding. Weighting
issues, as well as statistical analysis were run in SUDAAN (19) due to the
correlated multi-stage design inherent in NHANES.
NHANES is a complex survey sample (5) . The design and weighting
methods utilized in NHANES have been similar over the history of the survey.
Sampling weights must be used to account for: 1) probability selection (multi
stage), 2) over-sampling of non-Hispanic Blacks, Mexican-Americans, low
income persons, adolescents aged 12-19 years, and persons over 60 years of
age, 3) and non-response rates to interview and examination components (i. e. ,
missing data). Sampling weights produce unbiased national estimates (3). "The
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sample weight of a sampled person is the estimated number of individuals in the
population which the person represents" (12).
A six-year weight for each person who attended the MEC following a
morning fast was created for this study. Fasting weights provide national
representative population estimates based on a sub-sample who attended the

·

morning MEC examination in fasting conditions. Using a provided fasting weight
variable in the N HANES data set, the six-year weight variable was created by
taking 2/3 of the four year weight for each person sampled in 1999-2002
(WEIGHT6=2/3*WTSAF4YR) and 1/3 of the two year weight for each person
sampled in 2003-2004 (WEIGHT=1/3*WTSAF2YR). The final six-year weight
variable was WTSAF6YR (3).

Variance estimation
Variance estimation or sampling errors were also addressed. Following
the NHANES 1999-2000 release of the data as public use files, confidentiality
principles prohibited the release of the PSU variable. I n the 1 999-2000 N HANES,
replicate weights were produced and a jackknife procedure was recommended
for variance estimation (7). However, this procedure was not applicable for
multiple two-year data sets. The new method for variance estimation protects
confidentiality and allows the use of PSUs: ThisrtOVel approach creates Masked
Variance Units (MVUs) which can be used to estimate sampling errors. These
MVUs have been developed in a way that permits them to be utilized with any
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combination of data without recoding. Data were sorted by the design variables
SDMVSTRA and SDMVPSU before analysis (3). ·

Statistical Analysis

A total of 54 data files were downloaded and managed in this study. The
data were initially managed utilizing SAS 9.1 (20). SAS was used to conduct both
complex variable recodes and data coding validation.
SAS-callable SUDAAN (19) was then utilized to conduct the. analysis
regarding the three research questions posed in this study. SUDAAN
incorporates sampling weights within the context of the correlated multi-stage
complex sampling design inherent to NHANES (3). Research question 1: "What
is the current prevalence of the Metabolic Syndrome in the United States adult
population according to the National Heart, Lung, and Blood Institute definition?"
will be answered 'using PROC DESCRI PT. PROC DESCRI PT allows age
adjusted prevalences to be estimated. The age-adjusted prevalence of the
metabolic syndrome was computed using the direct method based on the 2000
U.S. population (22).
Logistic regressioA using PROC RLOGIST was used to estimate odds
ratios for being diagnosed with the metabolic syndrome (metabolic syndrome yes
versus metabolic syndrome no) in addressing research questions 2 and 3. For
research question 2, "Is there an inverse association for LTPA and the metabolic
syndrome when utilizing a measure of LTPA volume (MET·min·wk-·1 )?" a logistic
regression model was utilized for the six-level MET·min·wk· 1 independent
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measure to focus on a possible inverse association. Research question 3, "Is
there an inverse association for physical activity and the metabolic syndrome
when measuring physical activity from the parameters of the CDC/ACSM
physical activity public health recommendation?" PROC RLOGIST was also
utilized to estimate the likelihood of having the metabolic syndrome based on
meeting the current public health PA recommendation (18), being active but not
meeting the recommendation, and being physically inactive. Multiple logi�tic
regression (PROC MULTI LOG) was then used to estimate the OR and 95% Cl of
accumulating additional CV risk factors using the MSRS as the dependent
variable with LTPA being the primary independent variable.

Limitations
Aspects of the NHANES 1999-2004 may limit the findings in this study.
The most recent data from NHANES were collected from 1999 to 2004, thus the
prevalence estimates of the metabolic syndrome and the association with PA
may not reflect the association in the current U.S. population. PA data was self- :
report over the past 30 days, thus frequency, intensity, duration, and type of PA
is subject to recall bias. While cognitive te_sting has been done, the reliability and
validity of the PA has not been tested. Furthermore, this was a cross-sectional
study, thus causality cannot be established.
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Summary

The three research questions in this study were: 1) "What is the current
prevalence of the Metabolic Syndrome in the United States adult population
according to the AHA/NHLBI definition?", 2) "Is there an inverse association for
LTPA_ anc;I the metabolic syndrome when utilizing a measure of LTPA volume
(MET·min·wk-1 )?", and 3) "Is there an inverse association for physical activity -and ·
the metabolic syndrome when measuring physical activity from the parameters of
the CDC/ACSM physical activity public health recommendation?" The questions
are presented to estimate the current prevalence of the metabolic syndrome and
to examine the relationship between LTPA and the metabolic syndrome
according to the AHA/NHLBI definition in the U.S. adult population.
This is the first study to estimate metabolic syndrome prevalence and to
utilize the most sensitive measure of LTPA volume (MET·min·wk-1 ) to examine
the possible inverse association of LTPA with the METs in the U.S. adult
population using the most recent metabolic syndrome definition put forth. by the
AHA and the N HLBI.
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PART IV

The Relationship Between Leisure-Time Physical Activity and the Metabolic
Syndrome Among U.S. Adults: NHANES 1999-2004
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ABSTRACT .
Healthy People 201 0 identifies the metabolic syndrome metabolic syndrome as
an emerging health issue within the realm of cardiovascular (CV) disease. The
metabolic syndrome is a clustering of five CV risk factors that include poor
glucose control or diabetes, overweight/obesity, hypertriglyceridemia, low high
density lipoprotein cholesterol (HDL-C), and hypertension (HTN). An individual
that possesses three or more of these CV risk factors would be classified as
having the metabolic syndrome (15). The prevalence of metabolic syndrome in
adults is reaching epidemic proportions in the United States (U.S.) and
worldwide. Purpose: The purpose of this study was to two-fold. First, this study
examined the possible inverse relationship between leisure-time physical activity
(LTPA) and the metabolic syndrome. Secondly, this study evaluated the current
prevalence of the metabolic syndrome metabolic syndrome in a nationally
representative sample of the (U.S.) adult population within the 1 999-2004
National Health and Nutrition Examination Survey (NHANES). Methods: The
sample for this study-included adults, 20 years and older, (N=5,620) who
completed the mobile examination center (MEC) examination in the 1999-2004
NHANES.· The American Heart Association and National Heart, Lung, and Blood
Institute (AHA/NHLBI) definition was used to define the metabolic syndrome. A
metabolic syndrome risk score (MSRS) ranging from O (no risk factors present) to
5 (all five risk factors present) was created to sum CV risk factors in which
accumulating a MSRS �3 confirmed a metabolic syndrome diagnosis. Physical
activity (PA) was measured in two ways: a six-level measure based upon those
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reporting no LTPA (0 MET·minutes per week) and quintiles of LT PA, and a three
level measure (no LTPA, insufficient LTPA, and LTPA level meeting· CDC/ACSM
PA recommendation) associated with the current Centers for Disease Control
and American College of Sports Medicine public health PA recommendation.
SUDAAN statistical software was used to estimate age-adjusted metabolic
syndrome prevalence with logistic and multi-logistic odds risk ratios used to
examine the possible inverse association between LTPA and the metabolic
syndrome. Results: The overall age-adjusted prevalence of the metabolic
syndrome among the U.S. adult population was 36.3%. Adults who acquired
between 736 and 1360 MET·min-wk· 1 of LTPA were found to be 35°/o (OR 0.65;
95% Cl 0.48-0.88) less likely to meet the AHA/NHLBI metabolic syndrome
diagnosis criteria compared to those reporting no L TPA. A similar inverse
association was found against an increasing MSRS (OR 0.69; 95% Cl 0.560.85). A stronger inverse relationship was noted for those accumulating a weekly
· 1evel of LTPA MET-minutes coinciding with 60 ·minutes per day of moderately
intense PA (OR 0.55 ; 95% Cl 0.42-0.7 1). Similarly, this inverse association was
also (OR 0.58; 95% Cl 0.48-0.70) found at the same level of LTPA against an
increasing MSRS. Furthermore, a significant inverse association (OR 0.61; 95%
Cl 0.48-0.77) was also found for the metabolic syndrome when examining LTPA
by the CDC/ACSM public heath PA recommendation. Similar to LTPA
MET·minute volume, this inverse association (OR 0.64; 95% Cl 0.53-0.77)
carried over to the MSRS. Conclusion: Findings estimate one in three U.S.
adults have the metabolic syndrome which is consistent with other recent studies
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conducted using NHAN ES. This study consistently showed an inverse
association between LTPA the metabolic syndrome and underlying CV risk
factors. While this study is cross-sectional and causality · cannot be inferred , our
findings do illustrate an inverse association between LTPA and the metabolic
syndrome. These results support the need for future longitud inal stud ies and
randomized control trials examining PA volume and metabolic synd rome risk.
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Introduction

Healthy People 2010, the national health objectives for the United States, ·
identifies the metabolic syndrome metabolic syndrome as an emerging health
issue within the realm of cardiovascular (CV) disease (27). The metabolic
syndrome is a clustering of five CV risk factors that include poor glucose control
or diabetes, overweight/obesity, hypertriglyceridemia, low high-density lipoprotein
cholesterol (HDL-C), and hypertension (HTN). An individual that possesses three
or more of these CV risk factors would be classified as having the metabolic
syndrome. The prevalence of metabolic syndrome in adults is reaching epidemic
proportions worldwide ( 14) and it has recently been reported that one in three
American adults currently have the metabolic syndrome (11). This is important
because a metabolic syndrome diagnosis carries a two-fold increase in coronary
heart disease mortality (CHO) (12, 22) and a 40% increase in all-cause mortality
(22).
Researchers studying the metabolic syndrome and its underlying CV risk · .
factors have, to a large degree, focused on identifying the lifestyle behaviors that
might put a person at risk. One lifestyle-related behavior, physical activity (PA),
has been found to be consistently and inversely associated with metabolic
syndrome risk. As noted in a recent review by Ford et al. (14),· a large
contribution to our knowredge of a beneficial inverse relationship found between
PA and metabolic syndrome comes from research that has used nationally
representative population-based surveillance systems - one of which is the
National Health and Nutrition Examination Survey . (NHANES) (7). NHANES (7) is
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one of only a few surveillance systems around the world using a nationally
representative sample that simultaneously measures all of the CV risk factors
making · up the metabolic syndrome, in addition to measuring PA. To date, four
studies have utilized the NHANES to explore the relationship between_ PA and
the metabolic syndrome (9, 13, 23, 28).
Three studies utilized data from the 1988-1994 NHANES Ill.
Unfortunately, these PA and metabolic syndrome studies were limited in that the
assessment of PA only focused on the frequency and intensity of LTPA, with the
duration of LTPA being absent. Despite this limitation, we still gained some
insight into the relationship of the metabolic syndrome with PA. Park et al. (23)
was the first to explore the association of PA with the metabolic syndrome
utilizing a physical activity intensity score (PAIS) to measure the volume of LTPA.
The PAI S was defined by the ratio of work metabolic rate (METs) to resting
metabolic rate (RMR) obtained by a self-report recall of participation in various
types of LTPA over the previous 30 days (8). Creating a dichotomized variable
for LTPA (active versus inactive) based on the · PAIS, neither physically inactive
men (OR 1.4; 95% Cl 1_.0-2.0) or women (OR 1.2, 95% Cl 1.0-1.4) were found to
be at an increased risk for having the metabolic syndrome.
In another study utilizing the same NHANES Ill dataset and the LTPA
PAIS, Zhu et al. (28) created a three-level categorical variable: active (PAIS �
· 15. 0), moderately active (PAIS �3.6 to 14.9), and inactive (PAIS �3.5) to allow a ·
broader range of LTPA volume to be examined. After controlling for lifestyle- ·
related risk factors, males (OR 0.41; 95% Cl · O.31-0�54) and females (OR 0.25;
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95% Cl 0.18-0.37) in the most active PA group were found to be significantly less
likely to have the metabolic syndrome compared to the inactive group. Adults in
the moderately active group were not associated with a reduced risk for the
metabolic syndrome.
More recently, DuBose et al. (9) utilizing data from NHANES Ill examined
the relationship between LTPA and the metabolic syndrome- using a three level
categorical variable to define LTPA (inactive, irregularly active, and regularly
· active) with the regularly active level of LTPA representing the Centers for
Disease Control and Prevention and the American College of Sports Medicine
CDC/ACSM PA public health recommendation (24). Adults reporting being
inactive (no LTPA) were found-to be 45% (OR 1.45; 95% Cl 1: 17-1.79) more
· likely to have the metabolic syndrome compared to those reporting being
regularly active.
The most recent NHANES, beginning in 1999, measured PA from three
domains; LTPA, transportation, and domestic (7). In addition, this current .
NHANES collected more detailed information on PA, including frequency,
intensity, and duration. As a result, the current NHANES allows for a more
p·recise examination of PA volume with the metabolic syndrome and other
chronic diseases. Ford et al. (13), using data from NHANES 1999-2000 utilized . .
the sum of moderate/vigorous LTPA with domestic PA minutes per week

· ·

(min/wk) to create a three level PA variable (0 min/wk; < 150 min/wk; and � 150
min/wk). PA participation at any level was not found to · be associated with the
metabolic syndrome · (13).
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These conflicting NHANES results that illustrate the relationship between
PA and the metabolic syndrome might be related to the varying level of precision
by which PA volume was measured or utilized by researchers. For example, in
the three studies using NHANES Ill (8), duration was not collected in the PA self
report interview, thus one of the three necessary components for �ccurately
assessing PA volume was missing. Also, in the NHANES 1999-2000 study (1 3),
the researchers elected not to use data on intensity linked to each specific
activity which would have allowed MET·minutes per week to be calculated . .
Utilizing data from the most recent NHANES, an opportunity ·now exists to
more accurately measure LTPA volume and its relationship with the metabolic
syndrome using a more comprehensive and precise measure of L TPA volume .
. This measure, MET minutes per week (MET·min·wk-1 ) includes all the necessary
components to precisely measure PA volume: frequency, intensity, and duration;
With this in mind, the primary purpose of this study was to determine the
relationship between LTPA volume and metabolic syndrome risk, and the
secondary purpose of this study was to estimate the current prevalence of the
metabolic syndrome in a nationally representative sample of the U.S. adult
· population utilizing the most recent 1999-2004 NHANES .

Methods

This study utilized six years of data from the most recent 1999-2004
NHANES , a continuous survey conducted by the National Center for Health
Statistics (7). NHANES was designed to provide national estimates of the health
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and nutritional status of noninstitutionalized U.S. civilians over the age of two
months (7).

Sample
For the most recent six years of NHANES, the total· sample N is 3 1, 126,
ages two months and above. For this study, the final sample consisted of 5,620
U.S. adults � 20 years of age. The final sample met the following conditions: 1) ·
adult men and women � 20 years of age; 2) attended a morning medical
examination center (MEC) examination following an overnight fast (minimum of
eight hours); 3) if female, non-pregnant; and 4) had complete data on all the
variables of interest.

Measures

· AHAINHLBI Metabolic syndrome definition
The dependent variable in this study was a positive diagnosis of the
metabolic syndrome based on the American Heart Association and National
Heart, Lung, and Blood Institute (AHA/NHLBI) definition (15). The AHA/NHLBI
definition requires that three of the following · five CV risk factors be present for a ·
diagnosis of the metabolic syndrome: 1) impaired fasting glucose (I FG) � 100 .
milligrams per deciliter (mg/dL) or undergoing pharmacological treatment for I FG;
2) low high-density lipoprotein cholesterol (HDL-C) (< 40 mg/dL in men or < 50
mg/dL in women) or undergoing pharmacological treatment for an · abnormal ·
HDL-C level; 3) triglycerides � 150 mg/dL or undergoing pharmacolog·ical
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treatment for hypertriglyceridemia; 4) a waist circumference 0/VC) � 102
centimeters in men or � 88 cm in women; and, 5) blood pressure � 130/85
mm/Hg or undergoing pharmacological treatment for hypertension (HTN). The
AHA/NHLBI definition is unique in the respect that it precludes specific inclusion
criteria of any one condition found in all other medical society definitions-of th�
metabolic syndrome (15).
In creating a dependent variable based on a positive diagnosis of the
metabolic syndrome utilizing the AHA/NHLBI definition, data on blood pressure,
fasting glucose, lipoprotein values, and WC measurements were utilized from the
MEC, the health examination component of the NHANES. Each CV risk factor
was dichotomized with the dem·arcation being the cut-off value or pharmalogical
treatment for inclusion as a component of the metabolic syndrome (O= no risk; 1 =
risk). Risk factors were summed and a total metabolic syndrome risk score
(MSRS) was calculated which ranged from O (no risk factors) to five (all five risk
factors present). Those subjects with a score of 0-2 risk factors were determined
not to have the metabolic syndrome and those respondents with a score of 3 to 5
risk factors were determined to have the metabolic syndrome. In this study, the .
MSRS served as a secondary dependent measure utilized to examine the
relationship of LTPA to the metabolic syndrome.

Physical Activity
Data utilized to measure LTPA was accessed from the .'physical activities
individual activities file' (PAQIAF) (5). The PAQIAF is. one of the two files ·
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measuring LTPA and includes more detailed information regarding 43-specific
types of moderate and vigorous LTPA. The first measure, based upon LTPA
MET-minutes per week, took the number of times an activity was done ·over the
last 30 days and calculated an overall LTPA frequency per week. The
compendium of PA (1) was used to assign an appropriate MET level to each type of activity performed. Then the average duration (minutes per session), was used
in combination with the average frequency (number ·of sessions per week) and
the intensity level (MET-level) to calculate the MET minutes per week
(MET·min·wk-1 ) specific to each LTPA activity. With the sum of all LTPA
METmin·wk·1 performed, we created a "Weekly LTPA MET·minutes" measure.
In order to be able to examine a possible inverse association between
LTPA and the metabolic syndrome, MET·min-wk- 1 was divided into a six level
ordinal variable. The first level represented those who reported performing no
LTPA during the past month, the -referent group for this study. This level included
all individuals who reported no moderate or vigorous L TPA. Thus, they received · .
a score of "O" M ETmin·wk·1 . In calculating the remaining five levels of this
measure, the METmin·wk· 1 were divided into · quintiles from the MET-min·wk· 1 :
measure: 1st quintile >0.0-�156.24 MET·min-wk·1 ; 2nd quintile >156.24-�393.10
· MET·min·wk· 1 ; 3rd quintile >393.10-�736.55 MET·min·wk�1 ; 4th quintile >736;55<1360.15 MET·min·wk·1 ; 5th quintile >1 360.15- MET·min·wk-1 • This was done to
account for the non-normally distributed and skewed PA measures inherent in
national population surveys (17).
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A second LTPA measure used to examine the possible inverse
association with the metabolic syndrome was a three-level categorical variable
based on the CDC/ACSM PA public health recommendation (24). Individuals
who met the CDC/ACSM PA recommendation of five days per week o_f moderate
intensity PA fo� 30 minutes, or three days per week of vigorous intensity PA for
20 minutes were classified as meeting the public health recommendation;
individuals who engaged in LTPA at least one time per week at any duration or
intensity but not meeting the CDC/ACSM recommendation were classified in the
·_ - some, but insufficient category; and those who reported performing no LTPA
were classified as inactive.

Other Measures

Other measures used in this research included demographic variables of .
age and race/ethnicity, and two markers of socioeconomic status (SES), i.e:
education and income. Education was categorized as completing less than 1ih
· grade, completing 1ih grade, or education beyond 1ih grade. Income was
· categorized as a percent of the poverty threshold (< 100% , -100 to · 199% , 200 to
299% , 300 to 399% , > 400%). The standardized poverty thresholds represent
dollar amounts that define poverty status while accounting for family size (6).
Falling below a poverty threshold of 100% demarcates living in poverty. I n
addition, we used measures associated with alcohol consumption, smoking
status, and family history of chronic disease(s), including heart-disease and
diabetes.
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Statistics .

The data in this study were initially managed using SAS 9. 1 (26). SAS was ·
used to conduct both complex variable recodes and data coding validation� SAS
callable SUDAAN (25) was then used to conduct the analysis, incorporating
sampling weights within the context of the correlated multi�stage complex
sampling design inherent to NHANES (4). Age-adjusted prevalence estimates·
were calculated used PROC DESCRI PT for demographic characteristics and the
additional covariates. For all prevalence estimates, non-overlapping 95% Cls will
indicate significance. Logistic regression (PROC RLOGIST) analysis was used to estimate odds ratios (OR) and 95% confidence intervals (Cl) for the metabolic
syndrome (dependent variable (DV)) and both measures of LTPA. Multiple
logistic regression (PROC MULTILOG) was then used to estimate the OR and
95% Cl of accumulating additional CV risk factors using the metabolic syndrome
risk score as the DV with both measures of LTPA.

Results
Metabolic syndrome prevalence

Applying the AHA/NHLBI definition, the overall age-adjusted prevalence of
the metabolic syndrome among the U.S. adult population was 36.3%; anq the
prevalence was similar for men 36.9% (95% Cl 34.4%-39.4%) and women 35.6%
(95% Cl 33.2%-38.0%) (See Table 1). The prevalence of the metabolic .
syndrome increased with age; 14.9% among those aged 20-29 years and 60. 0% . ·
among those 70-79 years of age. Specific to· race/ethnicity, Non-Hispanic Blacks
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Table 1. Metabolic Syndrome Prevalence According to the AHA/N H LBI Criteria
by Demographic Characteristics and Other Lifestyle-Related CV Risk Factors
Among U.S. Adults >20 Years - N HANES 1999-2004.

Gender
Male
Female
Age
20-29
30-39
40-49
50-59
60-69
70-79
�80
Race/Ethnicity
Non-Hispanic White
Non-Hispanic Black
Mexican-American
Other
Education
< High school
High school
> High school
Income (%poverty level)
<O - <1 00
�1 00 - <200
�200 - <300
�300 - <400
�400
Smoking
Current smoker
Previous smoker
Never smoked
Alcohol
Above moderation drinker
Moderate drinker
Non-drinker
Family history of heart d isease
Yes
No
Family history of d iabetes
Yes
No

Sample
N
5620

Weighted
Ratio

Age-adjusted
prevalence.
%
36.3

95% CI
34.5, 38. 1

2837
2783

49.3
50.7

36. 9
35.6

34.4. �9.4
33.2, 38.0

87 1
91 7
1 007
763
949
645
468

1 7.9
21.1
22.0
1 6.7
1 1 .2
7.3
3.8

1 4.9
23.5
34.8
48.7
59.6
60.0
48. 3

1 1 .6. 1 8.2
20.4, 26. 5
30. 1 , 38.7
44.6, 52.9
56.3. 63.0
54.7, 65.3
42.7, 54.0

2934
1 01 6
1 291
379

72.0
1 0.6
7.2
9.2

36.7
30. 8
41 .2
37.3

34.3. 39.2
27.9, 33.7
37.9, 44.4
31 .5, 43.0

1 792
1 302
251 5

20.3
26.0
53. 7

40.3
40.9
32.6

37.0, 43.6
37.2, 44.7
29.9, 35.4

874
1 342
846
628
1 470

1 2.8
2 1 .2
1 5.7
1 3.8
36. 5

· 38.5
38. 9
37.9
37.6
33.4 .

33.9, 43.2
35.3, 42.7
33.2, 42. 5
32.6, 42.7
30.4, 36.4

1 239
1 552
2822 .

24.4
26. 1
49.5

35.4
37. 1
36.3

32 .3, 38. 5
33.5, 40.6
33.3, 39.4

381
3088
1 859

8.3
62.0
29.7

31.5
34. 5
42 .4

27.2, 36.0
32 .3, 36. 8
38.9, 45.9

449
51 71

6.8
· 93.2

5 1 .2
35.5

43.0, 59.4
33�7, 37.4

451
51 69

5.7
94. 3

. 52.6
35.5

42.3, 63.0
33.6, 37.3

NHANES:c National Health and Nutrition Examination Survey. AHA/NHLBI= American Heart Association/National Heart, Lung, and Blood Institute.
CV= Cardiovascular. Cl= Confidence Interval.
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were fou nd to have the lowest overall- prevalence of the metabolic syndrome
(30.8%; 95% Cl 27.9, 33.7) while Mexican-Americans were found to have the
g reatest prevalence (41 .2 % ; 95% C l 37.9%, 44.4%) . I n addition, level of
educational attainment, lifestyle habits, and having fam ily h istory of heart disease
or diabetes were also associated with metabolic syndrome prevalence· in U .S:
ad ults (See Table 1 ).

Metabolic syndrome prevalence by L TPA MET·minutes and the CDC/A CSM
recommendation
Table 2 illustrates the prevalence of the metabolic syndrome among U.S.
-

adults by weekly L TPA M ET·minutes and according to the current CDC/ACSM
public health PA recommendation . When exami n ing metabolic syndrome · prevalence by the LTPA quintiles of weekly MET minutes fou nd in Table 2 , there
was an inverse relationship ·found between LTPA weekly M ET· minutes and the
prevalence of the metabolic-syndrome. The lowest metabolic· syndrome
prevalence (27.2%; 95% . Cl 22.7-3 1 .7) was found among those reporting the
g reatest volume of LTPA and was significantly d ifferent than from those reporting
no LTPA and those reporting weekly L TPA MET;minutes falling within the first
three quintiles of activity (See Table 2).
· When focusing on the CDC/ACSM public health PA recommendation , a
significant d ifference was found·for m·etabolic syndrome- prevalence between
those meeting the current public health PA recommendatiori, 29.0% (95% Cl
25. 5-32 .6) and those reporting no LTPA,· ·40.0% (95% C l 37.5-42.6). The
1 36

Table 2. Metabolic Syndrome _Prevalence by Weekly LTPA and the CDC/ACSM
Public Health PA Recommendationt Among U.S. Adults �20 Years - NHANES
1 999-2004.
Age-adjusted
prevalence
Weekly LTPA MET minutes
%
40. 0
0.0
41 .2
>0.0 - �1 56 .24
> 1 56.24 - �393. 1 0
37.2
36. 3
>393. 1 0 - �736.55
29. 5
>736. 55 - �1 360. 1 5
27.2
> 1 360. 1 5
Weekly LTPA M ET minutes
Inactive
Insufficiently active*
Meets Recommendation t

%

40.0
. 37.6
29.0

95% CI

37.5, 42.6
36. 8, 45. 7
32.9, 4 1 .4
31 .8, 40.8
24.5, 34.6
22.7, 3 1 . 7
95% CI
37.5, 42.6
35. 1 , 40. 0
25.5, 32.6

AHA/NHLBl=American Heart Association/National Heart, Lung, Blood Institute.
CDC/ACSM=Centers for Disease Control and Prevention I American College of Sports Medicine.
LTPA= Leisure-time physical activity; CV= Cardiovascular disease. PA=Physical activity.
t Every US adult should accumulate 30 minutes or more of moderate-intensity physical activity on most, preferably
all, days of the week and/or 20 minutes of vigorous physical activity on three days of the week (24).
"'Physically active but insufficient to meet CDC/ACSM recommendation (24).
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metabolic syndrome prevalences for those reporting some LTPA 37.6% (95°/c, CI
35. 1-40.0) and no LTPA, 40.0% (95% Cl 37.5-42 .6) were foqnd to be quit�.
similar (See Table 2).

Metabolic syndrome and L TPA MET·minutes per week
Table 3 illustrates the OR for a metabolic syndrome diagnosis and the OR
for adding one additional CV risk factor inherent within the MSRS by LTPA
weekly MET- minute volume. Adults who acquired between 736.55 and 1360. 15
MET·min-wk-1 of L TPA were found to be 35% (OR 0.65; 95% Cl 0.48-0.88) less
. likely to meet the AHA/NHLBI metabolic syndrome d iagnosis criteria compared to
those reporting no LTPA; and those reporting > 1360. 15 MET·min·wk·1 were
found to be 45% (OR 0.55; 95% Cl 0.42-0.71) less likely to have the metabolic
· syndrome compared to those reporting no LTPA (0 MET·m in·wk·1 ).
When exam ining. the risk of increasing the metabolic syndrome risk score
(MSRS), decreased CV risk was also found beginning at the fourth quintile of
L TPA (See Table 3) . Adults who acquired between 736 .55 and 1360. 15
MET·min·wk·1 of LTPA were found to be 3 1% (OR 0.69; 95% Cl 0.56-0.85) less .
likely to accumu late one additional CV risk factor compared to those reporting no
LTPA. Furthermore, those reporting > 1360 . 15 MET�min·wk-1 were found to be
42% (OR 0.58; 95% Cl 0.48-0.70) less likely to add an additional CV risk factor.
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Table 3. Odds Ratios of Metabolic Syndrome diagnosis and Increasing
Metabolic Syndrome Risk Score (MSRS) by LTPA* Weekly METminutes ·
NHANES 1 999-2004.
Metabolic synd rome risk
Risk of increasing
by LTPA level
MSRS
Weekly LTPA MET minutes
0.0
=:,-0.0 - �1 56.24
>1 56.24 - �393. 1 0
>393. 1 0 - �736.55
>736.55 - �1 360. 1 5

>1 360. 1 5

Odds ratio
1 . 00
1.17
0.99
0.86
0.65

0.55

95% CI
0.94, 1 .4�
0.81 , 1 .23
0.66, 1 . 1 2
0.48, 0.88

P value .
for trend
0.0001

Odds ratio

0.42, 0.71

1 .06
0.97
0.79
0.69
0.58

95% CI
1 .00
0.86, 1 .32
0.79, 1 .20
0.62, 1 .0 1
0.56, 0.85
0.48, 0.70

· covariates adjusted for in the model include gender, age, race/ethnicity, education, income, smoking status,
alcohol intake, family history of heart disease, and family history of diabetes.
1
•LTPA= Leisure-time physical activity. MET=Metabolic equivalent (1 MET= 3.5 ml/kg/min- )
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P value
for trend
<0.000 1

Metabolic syndrome and the CDC/ACSM public health PA recommendation
Table 4 illustrates the OR of metabolic syndrom� diagnosis and. the· OR for
adding one additional CV risk factor in the MSRS by the CDCIACSM public health PA .
recommendation examining LTPA. Compared to those who reported being inactive (no
LTPA), participants who reported a volume of LTPA meeting or exceeding_ the current.
CDC/ACSM public health PA recommendation were found to be 39% (0.61; 95%
Cl 0.48-0. 77) less likely to have the metabolic syndrome compared to those
reporting no LTPA. When examining the risk of accumulating one additional CV
risk factor (MSRS), those meeting or exceeding the ·current CDC/ACSM PA
recommendation with LTPA were found to be 36% (OR 0.64; 95% Cl 0.53-0.77)
less likely to accumulate an additional risk.
· Note: Alternate findings from examining total PA from all three domains and· a
brief discussion can be found in Appendix C . .

. Discussi.on ·
With the most recent 1 999-2004 NHANES data and the metabolic ·
syndrome definition proposed by the AHA/NHLBI (1 5), this study found that
36.3% of the U.S. adult population can be classified as . having the metabolic
syndrome. This study represents the first national prevalence estimate of the . .
metabolic syndrome in the U.S. adult population usiog the AHA/NHLBI definition
and is similar to metabolic syndrome prevalence estimates found by Ford (11)
utilizing the International Diabetes Federation and World . Health Organization
definitions in 1999-2002 NHANES; These findings also illustrated a strong
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Table 4. Odds Ratios of Metabolic Synd rome diag nosis and I ncreasing Metabolic
Syndrome Risk Score (MSRS) by CDC/ACSM public health PA recommendation•
{LTPA) -NHANES 1 999-2004
LTPA Level
Inactive
Insufficiently activet
Meets PA recommendation•

Metabolic syndrome risk
by LTPA level
P value
Odds ratio
95% Cl
for trend
0.0003
1 .00
0.86, 1 . 1 5
0.99
0.48, 0.77
0.61

Risk of increasing
MSRS
95% CI
Odds ratio
- p value
for trend
1 .00
0:0001
0.81, 1 .07
0.93
0.64
0.53, 0.77

Covariates adjusted for in the model include gender, age, race/ethnicity, education , income, smoking status,
alcohol intake, family history of heart disease, and family history of diabetes.
CDC/ACSM=Centers for Disease Control and Prevention / American College of Sports Medicine.
LTPA= Leisure-time physical activity; CV= Cardiovascular disease.
··Every US adult should accumulate 30 minutes or more of moderate-intensity physical activity on most, preferably
all, days of the week and/or 20 minutes of vigorous physical activity on three days of the week (24).
t Physically active but insufficient to meet CDC/ACSM recommendation (24).
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inverse association between LTPA and the metabolic syndrome. Beginning with
a LTPA volume of 736.55 weekly MET·minutes, .adults that .met or surpassed .this
level of LTPA were 35% lesslikely to be classified as t,aving the metabolic
syndrome. A similar inverse association (OR 0.6 1; 95%

91 0.48-0.77) was

observed when PA was coded to represent the CDC/ACSM public health PA
recommendation. Furthermore, a similar inverse association (OR 0.64; 95% Cl
0.53-0.77) 'for meeting the CDC/ACSM public health PA recommendation was
found when examining the metabolic syndrome risk score (MSRS). It appears
that in order to reduce the risk of the metabolic syndrome through LTPA, an adult
needs, at a minimum, to meet the current CDC/ACSM public health PA
recommendation (24).
Our findings concur with previous epidemiological PA studies that have
examined the relationship between PA and the metabolic syndrome utilizing the
1988-1994 NHANES Ill (9, 28). Zhu et al. (28) found that men and women who
reported the greatest volume of LTPA were 59% and 75%, respectively, less
likely to have the metabolic syndrome. DuBose et al. (9) when examining the
potential association between LTPA and metabolic syndrome, with the most
active participants being the referent group, found that those adults who reported
no LTPA were 45% more likely to have the metabolic syndrome. In the present
study, the metabolic syndrome prevalence of 40.0 % in the inactive group
translates into this group being 65% (OR 1.65; 95% Cl 1.3 1-2.08) more likely to· ·
. be classified with the metabolic syndrome when compared to those meeting the
CDC/ACSM public health PA recommendation. ·
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Interestingly, in a study utilizing the most recent NHANES data, Ford et al.
( 1 3), found no sig�ificant association between PA and th_e met�bolic syndrome.
,
However, Ford et al. only utilized frequency and duration to measure PA in total
minutes per week. The current study linked each specific LTPA with a specific
MET level from the compendium of PA ( 1 ) to create a total MET-minut�s per
'

'

week, a more precise measure of LTPA volume. It appears that using this more
precise measure of LTPA allows for a more accurate analysis of the association
between LTPA and the metabolic syndrome.
In further examining LTPA volume, as it relates' to the metabolic
syndrome, the magnitude of the inverse association increased (OR 0.55; 95% Cl
0.42-0.71) for adults who accrued > 1 360.1 5 weekly MET·minutes of LTPA. This
volume of LTPA (i. e. 60 minutes per day of moderately intense PA) coincides
with the AHA and ADA PA recommendation (1 6) for the clinical management of
the metabolic syndrome. This additional benefit was not only observed for being
diagnosed with the metabolic syndrome, but also when examining the odds of an
increasing metabolic syndrome risk score (MSRS) that ranged from O (no risk) to
5 (all five CV risk factors present). This recommended volume of LTPA may be ·
preferable by physicians and other health care professionals working with
populations at risk for developing the metabolic syndrome. Greater volumes of
LTPA may increase the likelihood that these populations will be- able to lose or
maintain a healthy weight, thus reducing the risk of the metabolic syndrome.
However, motivating people to become physically active is a difficult task an.d
with the findings in this study suggesting the current CDC/ACSM public health
1 43

PA recommendation for health translate over to a possible reduction in the risk of
the metabolic syndrome, recommending 30 n:,i�utes pe� day of moderate!y .
intense PA may be prudent.
To date, no randomized control trials (RCTs) examining the role of the
.

.

.

.

'

CDC/ACSM public health PA recommendation with the prevention of the
metabolic syndrome as the primary outcome have been conducted. The closest
smaller prospective studies toward this end were conducted by Laaksnen et
al.(21) and Ekelund et al. (10). Laaksnen et al. (21), in ·a prospective study found .
that middle-aged men who met the current CDC/ACSM PA recommendation,
through structured ·or other lifestyle PA, were half as likely to develop the .
metabolic syndrome compared to men engaging in no more than 60 minutes of
moderate exercise per week. In another prospective study, Ekelund et al. ( 10)
reported that middle-aged men who had a physical activity energy expenditure .
(PAEE) equivalent to one hour per day of brisk walking were found to have a
significantly lower risk of developing the metabolic syndrome. Perhaps there is .
enough evidence from this and other studies (2, 9, 10, 19) to warrant RCTs that
focus on identifying the precise volume of PA that coincide with the current
CDC/ACSM public health PA recommendation (24) and the PA recommendation
issued by the AHA and ADA (16).
One of the weaknesses of physical activity epidemiology studies related to
the metabolic syndrome is the lack of a standardized measure. U nlike NHANES
1 1 1 , the current NHANES assessed frequency, intensity, and duration of PA, thus
allowing investigators to more precisely examine association between LTPA and
1 44

metabolic syndrome risk. Unfortunately, despite the precision of our LTPA
measure of weekly MET·minutes, it is not possible to directly compare our
findings to thc;,se from previous studies · (9, 13, 28) examining PA and metabolic
syndrome risk in NHANES.

Study limitations

These findings must be interpreted in light of the potential limitations. First,
· the cross-sectional nature of the study design does not allow causality to be
inferred. Second, recall bias was possible due to LTPA being assessed by a self
report interview from a frame of reference of the previous 30 days. Third, LTPA,
smoking, and alcohol·responses may have been subjected to the social
desirability effect _(i. e. providing answers to impress or please interviewer). Lastly,
dietary factors. (i. e. caloric intake) were not controlled due to the complex nature
of this data inherent to 1999-2004 NHANES.

Conclusion

Our findings estimate one in three U.S. adults have a Metabolic Syndrome
Risk Score (MSRS) classifying them as having the metabolic syndrome.
Metabolic syndrome risk and the risk associated with MSRS were found to be
inversely associated with increasing LTPA volume. This is consistent with the
majority of metabolic syndrome studies examining the association with PA (14).
In addition, the magnitude of the inverse association between LTPA and the
metabolic syndrome becomes greater when LTPA volume increases. However,
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longitudinal studies and RCTs using population-based methodology are needed
to reaffirm this study and previous smaller prospective studies · (3, 10, · 1a-21).
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APPENDIX A
The Metabolic Syndrome: How Definition Impacts Prevalence and Risk in
U.S. Adults
NHANES 1 999-2002
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Abstract
Pu rpose: To examine the relationships various definitions have on Mets

prevalence and risk estimates among a national sample of adults. Methods : The
.sample for this study-included adults, 20 years and older, (N=3745) who
completed the mobile examination center (MEC) examination jn the 1999-2002
National Health and Nutrition Examination Survey (NHANES). SUDAAN
statistical software was used to estimate age-adjusted prevalence and odds risk
ratios. Results: The overall age-adjusted Mets prevalence ranged from a high of
39.5% (ACE/AACE), to a low of 22.0% (WHO). For most Mets definitions, males,
people in the seventh decade of life (60-69 years of age), Mexican-Americans,
those without a high school education, and those living in poverty were found to
have the greatest prevalence. Corresponding to prevalence estimates, females
were 23% to 30% less likely to be diagnosed with the Mets. People in the
· seventh decade of life, Mexican-Americans, those With less than a high school
education and those .living in poverty were found to have the greatest risk for
· being diagnosed with the Mets. Conclusion: Mets prevalence and risk
estimates within populations are highly dependent on the requisite criteria and
definition used.
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Introduction
The aggregation of multiple cardiovascular risk factors was first observed
by Kylin early in the twentieth century (50), when he reported a syndrome that
included the clustering of hypertension (HTN), hyperglycemia, and
hyperuricemia. Subsequently, Kylin's syndrome was expanded through the work
by Vague (70) who proposed adding central adiposity and diabetes, and Avogaro
(7) who added obesity, both of which strengthened the relationship between the
clustering of risk factors and cardiovascular disease (CVD). In a landmark paper,
Reaven (62) described a series of abnormalities called "Syndrome X", which
included insulin resistance (IR), glucose intolerance, HTN , hyperinsulinemia,
elevated very low-density lipoprotein (VLDL) triglycerides, and low high-density
· lipoprotein cholesterol (HDL-C). This clustering of metabolic abnormalities, or the
metabolic syndrome (MetS)·as it is most commonly known today, has had many
labels over the past four decades, including special metabolic syndrome (47),
syndrome X (62) , the deadly quartet (48), insulin resistance syndrome (43), and
the plurimetabolic syndrome (28).
· This abundance of syndrome names is congruent-with the competing
criteria for defining the Mets. These competing criteria and their associated
prevalence estimates often lead to confusion for the clinician and researcher
alike (10). Previous Mets prevalence estimates in United States (U.S.) adults
range from a low of 7% in persons aged 20-29 years to a high of 44% to those in
the seventh decade of life (38). Mets prevalence has been shown to vary
depending on which medical society definition is adopted (9) . To date, there is no
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consensus for a definition between the five most commonly used medical society
definitions that measure the Mets (See Table 1) .. Several investigators have
attempted to identify the best working definition by comparing multiple definitions
(9, 27, 30, 5 1, 7 1). However, only 11 studies h�ve been conducted utilizing
national surveillance data (4, 6, 14, 16, 17 , 35-38, 42, 49).
Cameron et al. ( 16), summarized two studies that have reported using a
nationally representative sample (17, 3 1). Overall prevalence estimates from the
Australian Diabetes, Obesity and Lifestyle Study (AusDiab) (3 1) were reported to
be 15.9% for the European Group for the Study of Insulin Resistance (EG IR)
definition (8), 18.3% for the National Cholesterol Education Program (NCEP)
definition (55), and 20.9% for the World Health Organization (WHO) definition
(72). The other prevalence estimate in this review originated from a national
sample of Mauritians in which prevalence estimates ranged from a high of 19. 1 %
(WHO) to a low of 1 3.8% (NCEP) ( 17):
Since the Mets has become a focal point of metabolic research, several
researchers have used national representative samples in reporting prevalences
- (4, 6, 14, 35, 37, 39, 42, 49), but most investigators utilized only one definition.
Ford (36, 37), using data from the National Health and Nutrition Examination
Survey (NHANES) has taken . the lead in contrasting prevalences of the Mets
.using various published definitions. Ford (2003) initially reported national
prevalences of the Mets using the WHO (1999) and · the NCEP (2001 ) definitions.
The age-adjusted prevalence of the Mets in U.S. adults � 20 years. in NHANES
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Table 1 . Metabolic syndrome definitions from various medical societies.
WHO
Requisite criteria

1999

2003

2005

EGI R _,999

ACE/AACE

IGT, IFG,

Insulin in top

High risk a; BMI

Waist �94 cm (men)

type 2 diabetes,

quartile of

>25 or waist

and �80 cm

insulin in top quartile

population

>1 02 cm (men)

(women),

or >88cm

population specific

(women)

for ethnic groups b

of population

IDF

AHA/N HLBI

2005

NIA

Other Criteria

Plus � 2 of:

Plus � 2 of:

Plus � 2 of:

Plus � 2 of:

� 3 of:

Glucose

N/A

�1 00 mg/dl,

�1 00 mg/dl,

�1 00 mgidL,

�1 00 mg/dl,

2-hour post OGTT

2-hour post OGTT

diabetes

diabetes

�1 40 mg/dl but

�1 40 mg/dl but

not diabetes

not diabetes

W:H ratio >0.9

Waist � 94 cm in

NIA

NIA

Waist �1 02 cm in

in men or >0.85

men

men

in women; BMI

or �80 cm in women

or �88 cm in women ·

-I.

Obesity

>30
Lipids

TG �1 50 mg/dl

TG > 1 80 mg/dl

TG > 1 50 mg/dl

TG �1 50 mg/dl

TG �1 50 mg/dl or

_Table 1 . Metabolic syndrome definitions from various medical societies (contin ued}.
and/or H DL-C

and/ or

or HDL-C <40

or Rx or HDL-C <40

HDL-C <40 mg/dl in

<35 mg/dl in men

HDL-C<39 mg/dl

mg/dl in men

mg/dl in men

men or <50

or <50 mg/dl in women

or <50 mg/d/L in

mg/dl in women or Rx

or <39 mg/dl in

Hypertension

Other

. in men or women or

women or Rx

women

RX

�1 40/90 mm Hg

�140/90 mm Hg

> 1 30/85 mm Hg

�1 30/85 mm Hg

�1 30/85 mm Hg

or Rx

or Rx ·

or Rx

or Rx

or Rx

Microalbuminuria
ACR �30mg/g

01
CX)

WC, waist circumference; W:H, waist hip; TG, triglycerides; QGTT, oral glucose tolerance test; Rx. medication; ACR, albumin: creatinine ·
ratio; others designated in text. WHO=World Hea.lth Organization EGIR=European Group for the study of Insulin Resistance
AHA/NHLBl=American Heart Association/National Heart, Lung, and Blood Institute ACE/AACE=American College of
Endocrinology/American Association of Clinical Endocrinologists IDF=lnternational Diabetes Federation.
.
.
a Family history of type 2 or gestational diabetes,. known CVD, polycystic ovary syndrome, physically inactive lifestyle, >40 years of age,
.

and ethnic populations at high risk for a type 2 diabetes. ··
b Mexrcan-A.m erican men waist circumference cut-off point is � 90 cm .

Ill was 25.1% (WHO) and 23.9% (NCEP). In a follow-up study using data from
the most recent NHANES 1999-2002, Ford (36) contrasted the NCEP and
International Diabetes Federation (46) criteria for the Mets, reporting
prevalences of 34.6% and 39.1 %, respectively.
To date, no one study has compared prevalence estimates of all five
commonly used medical society definitions described in Table 1. This study
examines the prevalence estimates for all of these definitions using the NHANES
(1999-2002) national database, thus extending the previous work of Ford by
three definitions. In addition, risk profiles for being diagnosed with the Mets
specific to each definition will be examined.

Methods

This study utilized data from NHANES, a continuous survey conducted by
the National Center for Health Statistics (21). In 1999, the National Center for
Health Statistics (NCHS) began releasing public use data files continuously as
smaller component-specific data files on an ann·ual basis. The most recent
survey was conducted from 1999 through 2004 and ·represents the eighth series
of surveys. These surveys were designed to provide national estimates of the
health and nutritional status of noninstitutionalized U . S. civilians over the-age of
two months.
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Sample
The- 1999-2002 NHANES databases contain information on 2 1,004
individuals over two months of age. Complete data assuring full fidelity for all five
Mets definitions in this study was not released at the time of our analysis,
therefore-only the first four years of data was utilized in our investigation. The
sample for this study-included non-Hispanic White, non-Hispanic Black, MexicanAmerican, and the Other race/ethnicity category, aged 20 years and older
(N=9,688). Eligible participants for this study attended the mobile examination
center (MEC) following an overnight fast (minimum· a hours) and received a
clinical exam up. Women who reported being pregnant were excluded. Complete
data, for the final sample in our study, included 3,745 adults.

Measures
The five demographic variables utilized in our analysis incJuded gender,
age, race/ethnicity, and two markers of socioeconomic status (SES), i. e.
education and income. Education was categorized as completing less than 12th
· grade, completing 1ih. grade, or education beyond 1ih grade. Income was ·-.
categorized as a percent . of the poverty threshold (< 100, 100 to 199, 200 to 299, · 300 to 399, > 400). The . standardized poverty thresholds represent dollar
amounts that define poverty status while accounting for family size (22). Falling
below a poverty threshold of 100% demarcates living in poverty.
The collection of blood and urine was performed in the MEC during the
clinical examination. These samples were obtained in order to measure specific
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variables, allowing researchers to examine risk profiles. The data utilized from
blood samples in this study were fasting plasma insulin . values to verify meeting
the top population quartile, demarcating IR, HDL-C and triglyceride values to .
· classify dyslipidemia,· and blood glucose values in order to classify IFG. The data
utilized from the urinanalyis was for the classification of microalbuminuria (high
protein levels in the urine. Detailed specimen collection and processing
· instructions are d iscussed in the NHANES Laboratory/Med ical Technologists
Procedures Manual (LPM) (20). Three or four blood pressure (BP) readings- were
taken in the MEC and the average was reported for analysis (60). In addition,
participants were asked as part of the home interview process if they have ever
been told by a doctor or health care professional that they had diabetes.

Metabolic syndrome definitions

This· study utilized five working medical society definitions proposed for the
diagnosis of the Mets. Table 1 summarizes the various definitions published by
the World Health Organization (WHO) (72), EGI R (8), American Heart
Association (AHA) and the National Heart, Lung and Blood Institute (NHLBI) ·.
definition (41) which refers to the updated NCEP . (2001) definition, the joint
American College of Endocrinology (ACE) and American Association of Clinical
Endocrinologists (AACE) consensus definition for epidemiological rese_arch (33),
and the IDF (46). The ACE/AACE definition represents the official position of an
· ACE/AACE task force appointed by the AACE president (33). To facilitate
comparisons, all five definitions reflect the change adopted by Grundy. and others
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(41, 46) put forth by the American Diabetes Association (1) for lowering the
diagnosing of I FG, lowering the cut-point from 110 mg/dl to 100 mg/dl. In
0

addition, we considered the current use of antihypertensive medication an
indication of high BP.
The majority of research that has been done on the Mets involved the use
of the NCEP, WHO, and EGIR definitions (See Table 1). The NCEP definition
requires that three of the following five criteria be present for a diagnosis of the
Mets: impaired fasting glucose (I FG), low HDL-C, elevated triglycerides, an
increased waist circumference (WC), or HTN � The NCEP definition is unique in
the respect that it precludes specific inclusion criteria of any one condition (e.g.
I FG) in order for Mets to be diagnosed. The most - recent definition put forth by
the AHA and NHLBI (41) mirrors the NCEP (55) definition with the following
modifications: medication use for those with dyslipidemia, HTN, and I FG
maintains the diagnosis, and the cut-off point for I FG was lowered from 110
mg/dl to 100 mg/dl to reflect the recent changes put forth. by the American
Diabetes Association (ADA) for I FG (1) .
The W_H O definition includes at least one of the following requisite
conditions: impaired glucose tolerance (IGT), I FG , type 2 diabetes (T2D) , or
insulin levels in the top quartile of the population plus two of the following: low
HDL-C or elevated triglycerides, a waist/hip (W/H) ratio >0.9 for men or >0.85 for
women or body mass index (BMI) > 30 kg/m 2 , HTN, or microalbuminuria. The
WHO definition recommends a hyperinsulinemic-euglycemic clamp technique
and an oral glucose tolerance test be used for estimating I R. Because these
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techniques were not employed in NHANES, fasting insulin concentrations were
utilized to estimate IR and IFG was utilized in place of IGT, which has been
previously recommended by EGIR (8). The EGIR definition requires insulin in the .
upper quartile plus two or more of the following: low HDL-C or elevated
triglycerides, WC of �94 centimeters (cm) for men and �80 cm for women, HTN ,
or IGT or IFG but not diabetes. The EGIR feels diabetes should be treated as a ·
separate entity (8). A key factor in T2D is beta-cell function , as this diminishes,
ability in estimating insulin sensitivity is abated (75).
In addition, the IDF and ACE/AACE definitions have beeri proposed. The
ACE/AACE definition requires one of the following: an individual to be classified
as high risk for IR, BMI >25 kg/m2 or WC of > 1 02cm in men or >88cm in women
plus at least two of the following: IFG or IGT but not diabetes, low HDL-C,
elevated triglycerides, or a diagnosis of HTN. The recent definition put forth by
the ·1 0F mirrors the AHA/NHLBI criteria except for the WC cut-points being
lowered and individuals taking medication(s) for hyperglycemia being included in
the IFG or diabetes category (See Table 1 ) .

Statistics

SAS (65) was used to recode the variables of interest, and SUDAAN (63)
was used to conduct the analysis: SUDAAN incorporates sampling weights within
the context of the complex sampling design inherent to NHANES (21 ). Age
adjusted prevalences for the Mets we·re computed using PROC DESCRIPT with
· opulation. Logistic regression ·using ·
the direct method based on the 2000 U .S. p
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PROC RLOG IST was used to estimate odds risk-ratios for being diagnosed with the Mets (Mets yes versus Mets no). With logistic regression we controUed for
gender, age, race/ethnicity, education, and income.

Results
Figure 1 displays two distinct phases of the Mets diagnosis process.
Phase 1 reflects the proportion of the US adult population who meet the requisite
condition(s) for each of the medical society definitions found in Table 1. The
requisite condition prevalences range from 27% (EG IR) to the entire eligible
sample (AHA/NHLBI). Subjects who met the requisite condition specific to each
definition were then subjected to the phase two diagnostic criteria indicative of
the Mets diagnosis. Figure 1, phase two, presents the Mets prevalence specific· ·
to each of the five medical society definitions. The two med ical society definitions
resulting in the lowest prevalence rates (EG IR, 22.7% ; and-WHO� 22.0%) were
found to have the lowest eligible pools for Mets diagno·sis. Approximately half of
those meeting the requisite criteria for WHO were found to have the Mets, while
more than 80% of those identified with the requisite condition for EGIR met the
diagnostic criteria for the Mets. The IDF and ACE/AACE definitions were
associated with the . highest prevalence rates (39.5% and 39. 1 % respectively).
Similar to the WHO definition, the ACE/AACE and IDF prevalence estimates are
approximately half of their respective eligible pools (See Figure 1). The
AHA/NHLBI definition, which allows more flexibility, requires no requisite
condition(s) and classifies one out of every three U.S. adults· as having the Mets.
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Requisite criteria prevalence specific to medical society definition
2
Mets prevalence for each medical society definition

Figure 1 . Prevalence of the Mets in US adults by diagnostic phase specific
to medical society definition.
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The overall age-adjusted and demographic-specific Mets prevalences
across the various Mets definitions are shown in Table 2. The overall age- ·
adjusted Mets prevalence was highest (39.5%) within the ACE/AAC� definition,
while the lowest overall prevalence (22·.0%) was found in the WHO definition. In
. two of the five definitions, males were found to have greater prevalences than
females. The exception was found with the AHA/NHLBI definition, where gender
related prevalences were identical. The greatest difference between male and
female Mets prevalence was found within the ACE/AACE definition with m�les at
42.7% and females at 36.0%. Prevalences varied for gender between definitions,
ranging from a low of 19.9% (EGIR) to a high of 36.8% (IDF) in females, and a
low of 22.6% (WHO) to a high of 42.7% (ACE/AACE) in males.
Specific to age, delineated by 10-year age groups, there was a consistent
increase in Mets prevalence through the seventh decade (60-69 years of age) of
life. Mets prevalence begins to decline or level off in the eighth decade (70-79.
years of age) of life; this is consistent across the various definitions except
ACE/AACE, where the drop in prevalence is not seen until the ninth decade �-ao
years of age); Across definitions, Mets prevalence values ranged from a low of
9.4%, (WHO) in the 20-29 year old age group, to a high of 60.3%, (ACE/AACE)
in the 70-79 year old age group.
MetS · prevalences specific to race/ethnicity, found Mexican-Americans to
have the highest overall age-adjusted prevalence across all definitions, with the
greatest prevalence rate being associated with the ACE/AACE defin.ition at
- 48�5%. The lowest race/ethnic prevalence rates were associated with non166

Table 2. Metabolic Syndrome prevalence specific to medical society defin itions by demographic characteristics
among U . S adults aged ?. 20 years, NHAN ES 1 999-2002.
EGIR1911

WH01111
N

%•

95% Cit

%•

95% Cit

2oos
IDF

ACE/AACE2003
%•

95% Cit

%•

95% Cit

AHA/NHLB12005
%•

95% Cit

Total Age-Adjusted Prevalence 3745 22.0 (20.3, 23.8) 22.7 (20.7, 24.6) 39. 5 (37.2, 41 .8) 39. 1 (37.4, 40. 1 ) · 36. 1 (34.3, 37.8)
Gender
Male

1 893

22.6 (1 9.8, 25.3)

25.5 (22.7, 28.3)

42.7 (39.0, 46.4)

41 .2 (38.3, 44. 1 )

36.3 (33.3, 39. 3)

Female

1 852

21 .4 (1 9.2, 23.5)

1 9.9 (1 7.4, 22.3)

36.0 (34.0, 38.0)

36.8 (34.6, 39.0)

35.6 (33.2, 37.9)

20-29

574

9.4 (5.8, 1 3.0)

1 2.3 (8.7, 1 5.9)

20.3 (1 6.3, 24.3)

1 8.5 ( 1 4.4, 22.6)

1 4.2 (1 0.4, 1 8.0)

30-39

623

1 4.8 (1 2.0, 1 7.6)

1 9.3 (1 6.2, 22.4)

26.2 (22.9, 29.6)

24.7 (21 .3, 28. 1 )

23.9 (20. 1 , 27.7)

40-49

692

20.6 (1 5.9, 25.3)

25.0 (20.2, 29.9)

40.4 (34.4, 46.4)

38. 7 (33.3, 44. 1 )

35.4 (30.5, 40.3)

50-59

523

28.0 (22.5, 33.4)

27.4 (2 1 .5, 33.3)

50.3 (44.4, 56.2)

51 .9 (47.2, 56. 5)

47.3 (43.5, 51 .2)

60-69

625

37.6 (32.2, 43.0)

34.8 (30.3, 39.3)

57.7 (52. 1 , 63.3)

63.2 (59. 1 , 67.2)

59.0 (55.3, 62. 7)

70-79

416

35.6 (30.5, 40.8)

23.9 (1 9.3, 28.4)

60.3 (54:0, 66. 7)

60. 1 (54. 7, 67.0)

58.7 (52�8. 64. 7)

> 80

292

31 .5 (24.2, 38.9)

1 9.5 (1 2.3, 26.6)

57.6 (51 .4, ,63. 8)

50.9 (43.6, 58.2)

49A (42.7, 56.0)

1 898

21 .7 (1 9.6, 23.9)

21 .8 ( 1 9.4, 24.2)

38.9 (35.6, 41 .9)

38.9 (36.6,, 41 . 1 )

35.7 (33.5, 37.8)

Age

�

. Race/Ethnicity
Non-Hispanic White

Table 2. Metabolic Syndrome prevalence specific to medical society definitions by demographic characteristics
among U . S adults aged � 20 years, NHAN ES 1 999-2002 (continued).
Non-Hispanic Black

663

23.8 (20.2, 27.3)

24.8 (2 1 .7, 27.9)

3 1 .4 (27.7, 35.2)

33.2 (29.6, 36.8)

31 .5 (27.7, 35.3)

Mexican-American

916

27.9 (24.7, 31 .0)

30.3 (27.8, 32.8)

48.5 (45.4, 5 1 .6)

48.4 (45.3, 51 . 5)

42. 7 (39.4, 46. 1 )

Other

268

1 9.9 (1 6.0, 23.8)

22.6 (1 7.0, 28. 1 )

44.5 (36.5, 52.5)

41 .9 (37.0, 46.9)

40.9 (34.7, 47.2)

< High school

1 251

24.0 (2 1 .2, 26.7)

26.2 (22.5, 29.9)

46.3 (42.2, 50.3)

45.8 (41 .9, 49. 8)

42. 1 (37.6, 46.6)

High school

839

25. 1 (2 1 .3, 29.0)

24.4 (1 9.5, 29.4)

43. 1 (37.9, 48.3)

42.8 (38. 1 , 47.6)

41 . 1 (36. 1 , 46. 0)

> Hig h school

1 647

1 9.8 (1 7. 1 , 22.6)

20.4 (1 7.5, 23.4)

35.3 (32.4, 38. 3)

34.9 (32.3, 37.5)

31 .3 (28.7, 33. 9)

< 0 -<1 00

579

25.4 (2 1 .3, 29.4)

26.8 (22.7, 30.8)

45.2 (38.6, 5 1 . 8)

40.3 (35.0, 45.6)

40.8 (34.0, 47. 7)

�1 00 -<200

851 ·

24.3 (20. 1 , 28.4)

24.3 (20.3, 28.4)

4 1 .3 (37.0, 45.7)

42.7 (38.4, 47.0)

38.4 (33.5, 43.3)

�200 -<300

544

23.8 (1 8.2, 29.5)

21 .0 ( 1 4.9, 27.2)

40.6 (34.3, 46.9)

37.2 (3 1 .4, 43,. 0)

37.6 (31 .2, 44.0)

�300 -<400

41 9

22.4 (1 6.9, 28.0)

21 .7 (1 5.7, 27.7)

42.3 (36.0, 48.5)

41 .8 (35.3, 48.4)

39.4 (32.5, 46.3)

999

1 9. 1 ( 1 6. 1 , 22. 1 )

2 1 .2 ( 1 8.2, 24. 1 )

35.0 (3 1 .4, 38. 5)

36.5 (34.0, 39. 0)

31 .6 (28.9, 34.3)

Education

-I.

I ncome {% of poverty level)

�400

.

I

•Percent prevalence. t95 percent confidence interval. WHO=World Health · Organization· EGIR=European Group for the st�dy of Insulin
. Resistance AHA/NHLBl=American Heart Association/National Heart, Lung, and Blood Institute AC E/AACE=American Coilege of
· Endocrinology/American Association of Clinical Endocrinologists IDF=l nternational Diabetes Federation.
.

:

.

Hispanic Blacks in three out of the five definitions (AHA/NHLBI, ACE/AACE, and
IDF). Non-Hispanic Whites had the lowest prevalence rate (21.8%) according to
the EGIR definition, and the "other'' race/ethnicity category had the lowest
prevalence (19.9%) specific to the WHO definition.
A focus on educational attainment found that the lowest Mets prevalence,
across all five medical society definitions, occurred in the group with the highest
level of educational attainment (> high school). For four of the five definitions, the
.

.

.

highest Mets prevalences were found in those who did not complete high school.
In addition, Table 2 shows while there is no consistent trend either between or
within definitions as reflected by poverty levels, those people below the 1 00%
poverty threshold for four of the five definitions were found to have the highest
prevalence-of the Mets.
After controlling for gender (not stratified by gender), age, race/ethnicity,
education, and poverty level in multivariate logistic regression, several consistent
risk factors were identified across the definitions (See Table 3). For three of the
five definitions, females were found to have a decreased likelihood of being
diagnosed with the Mets. This reduced risk for females ranged from 2_3 % to 30%.
These findings closely mirrored the difference in prevalences between males and
females found in Table 2.
After controlling for all other factors, our data indicate the risk of being
diagnosed with the Mets to be highly age-dependent, with risk increasing each
decade through the seventh decade of life. For four of the five definitions, people
in the seventh decade of life (60-69 years of age) were four to eight times more
169

Table 3. Odds ratios for being diagnosed with the metabolic syndrome specific to medical society definitions: U.S adults

aged � 20 years, NHANES 1999-2002.
EGIR,999

WHO,n9

1DF2005

ACE/AACE2uu3

AHA/NH LB l2005

Independent variab l es and
Adjusted

Adjusted

Odds ratio 95%

Odds ratio 95%

Cit

Male•
Female

. Adjusted

Adjusted

Adjusted

Odds ratio 95%

Odds ratio 95%

Odds ratio 95%

Cit

Cit

Cit

Cit

1 .00

1 .00

1 .00

1 .00

1 .00

0.93 (0.75, 1 . 1 5)

0. 70 (0.56, 0.87)

0.70

0.77 (0.64, 0.93)

0.94

20-29•

1 .00

1 .00 .

1 .00

1 .00

1 .00

30-39

1 .78 (1 .08, 2.91 )

1 .79 (1 .22, 2.64)

1 .50 (1 .08, 2.08)

1 .51

(1 .05, 2. 1 9)

1 .94

(1 .27, 2.97)

40-49

2.72 (1 .53, 4.83)

2.55 (1 .77, 3.69)

3.09 (2.02, 4.74)

3.26 (2. 1 4, 4. 97)

3.69

(2.46, 5.52)

50-59

4.42 (2.59, 7.56)

3. 1 3 (1 .98, 4.93)

4.82 (3.32, 7.00)

5.66 (4.07, 7.88)

6.56

(4.59, 9.39)

60-69

6. 1 9 (3.96, 9.68)

4.03 (2.76, 5. 87)

5.96 (4. 1 6, 8.53)

8.45 (6.25, 1 1 .41)

8.93 (6. 1 0, 1 3.05)

70-79

5.53 (3.05,

2.42 (1 .41 , 4. 1 5)

6.43 . (4. 1 1 , 1 0.05)

8. 1 0 · (5. 1 2, 1 2.79)

8.95 (5.68, 1 4. 1 0)

2.00 (0.97, 4. 14)

6.06 . (3.83, 9. 58)

5. 75 (3.80, 8. 72)

5;90

effects

Gender

(0.59, 0. 83)

(0.77, 1 . 1 4)

Age

1 0.03)
> 80

4.88 (2.56, 9.32)

(3.85, 9.05)

Table 3. Odds ratios for being diagnosed with the metabolic synd rome specific to medical society defin itions: U . S adults
aged � 20 years, NHANES 1 999-2002 (continued).
Race/Ethnicity
1 .00

Non-Hispanic White•

1 .00

1 .00

1 .00

1 .00

Non-Hispanic Black

1 .09 (0.83, 1 .45}

1 .09 (0.84, 1 .42}

0.67 (0.52, 0. 85}

0. 71

(0.55, 0.93}

0. 74 (0.57, 0. 97}

Mexican-American

1 .31

(0.94, 1 .84}

1 .44 (1 .08, 1 . 92}

1 .34 (1 .03, 1 .74}

1 .35 (1 .04, 1 .76}

1 . 1 7 (0.86, 1 .58}

Other

0.81 (0.58, 1 . 1 3}

0.99 (0.69, 1 .44}

1 .26 (0.87, 1 .82}

1 . 1 5 (0.86, 1 .54}

1 . 1 5 (0.83, 1 .57}

< H igh school•

1 .00

1 .00

1 .00

1 .00

1 .00

High school

1 . 1 3 (0.8 1 , 1 .56}

1 .01

(0.66, 1 . 55}

0.96 (0.72, 1 .27}

0.89 (0.64, 1 .24}

1 .02 (0. 72, 1 .43}

> High school

0.92 (0.69, 1 .2 1 }

0.86 (0.6 1 , 1 .2 1 }

0.69 (0.48, 0.99}

0.64 . (0.47, 0.88}

0.67 (0.48, 0.92}

< 0 -<1 00•

1 .00

1 .00

1 .00

1 .00

1 .00

�1 00 -<200

0.90 (0.68, 1 .20}

0.87 (0.64, 1 . 1 8}

0.83 (0.58, 1 . 1 9}

1 .03 (0.72, 1 .47}

0.88 (0.59, 1 .3 1 }

�200 -<300

0.88 (0.62, 1 .26}

0.67 (0.43, 1 .05}

0.85 (0. 59, 1 .24}

0.81 · co.6 1 , 1 .23r o.a8 co.58, 1 .33}

�300 -<400

0.80 (0. 5 1 , 1 .23}

0.70 (0.44, 1 . 09}

0.93 (0.64, 1 .33}

1 .02 (0.72, 1 .46}

0.98 (0.66, 1 .45}

�400

0.65 (0.47, 0.89}

0.70 (0.50, 0.96}

0. 70 (0.48, 1 .02}

o.84 co:62. 1 . 1 3}

0.70 (0.48, 1 . 02}

Ed ucation

-.Ji.

Income (% of poverty level)

•Referent group. t95 percent confidence interval. WHO=World Health Organization EGIR=European Group for the study of Insulin ·
·. Resis�ance AHA/NHLBl=American Heart Association/National Heart, Lung, and Blood I nstitute ACE/AACE=American College of
Endocrinology/American Association · of Clinical Endocrinologists IDF=l nternational Diabetes Federation.

likely to be diagnosed with the Mets compared to adults in the third decade of life
(See Table 3).
According to three of the five definitions, Mexican-Americans had the ·
greatest ri.sk for being diagnosed with the Mets compared to non-:-Hispanic
Whites. This increased risk ranged from 34% (ACE/AACE) to 44% (EGI R).
Conversely, a significantly lower risk for being diagnosed with the Mets was
noted for non-Hispanic Blacks in three of the five definitions. Non-Hispanic
Blacks were 29% to 33% less likely to be diagnosed with the Mets compared to
their non-Hispanic Whites counterparts (See Table 3).
For three of the five definitions (AHA/NHLBI , ACE/AACE, and I DF), Mets
risk was significantly lower in people with greater than a high school education.
After controlling for other factors, adults with this level of education were found to
have a 31% to 36% reduction in risk of being diagnosed with the Mets. In
addition, reduced risk ranging from 30% to 35% was found among adults in the �
400% poverty category, compared to those below the 100% poverty demarcation
(See Table 3). This risk reduction was only found in this most affluent group
within the WHO and EGI R definitions.

Discussion
To date, nationally representative Mets prevalence studies in the U.S.
comparing prevalences across definitions have only simultaneously employed a
maximum of two definitions (36, 37). Our study extends this earlier research by
simultaneously comparing the Mets prevalences for all five medical society
172

definitions using a nationally representative sample of the U.S. adult population
within 1999-2002 NHANES.
When examining the trends seen across the five working medical society
definitions, there appears to be two levels of prevalence - low (WHO and EGIR),
and high (ACE/AACE , IDF and AHA/NHLBI). The lower prevalence estimates
found with the WHO and EGIR definitions appear to be due to. the restrictive
nature of the requisite criteria (See Table 1). The eligible pools for each definition
as defined by the percentage of people . from our background population meeting
the requisite criteria are displayed in Figure 1. When examining the four
definitions with requisite criteria, the WHO, ACE/AACE and IDF definitions
estimate prevalence to be approximately half of their eligible pool. However, the
EGIR definition captures 84% of its eligible pool, thus suggesting insulin
resistance and/or hyperinsulinemia may be a more sensitive filter for Mets than
other· criteria. Previous research examining prevalence estimates of the Mets
1

and the individual components defining the syndrome has found there to be a
strong link between insulin resistance and hyperinsulinemia with the clustering of
risk factors that designate the Mets (26, 34, 43, 48, 61, 62, 74).
Excluding the AHA/NHLBI crrteria, for which a requisite condition is not
applicable, the specific requisite condition prevalence (phase 1) appears to serve
as a filter in the remaining definitions, thus impacting the risk pool eligible for
Mets diagnosis based on other criteria specific to each definition (See Figure 1).
In addition to the restrictive requisition criteria found in these low prevalence
definitions, additional restrictions are imposed through HTN and triglycerides:
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The moderate-level prevalence estimate of Mets associated with the
AHA/NHLBI definition is likely due to the liberal nature of the definition in that no
requirements or requisite conditions are imposed. In the absence of requisite
criteria within the AHA/NH LBI definition, any combination of three of the five
defining criteria for Mets diagnosis is plausible. The reason for this approach in .
defining the Mets was that the AHA/NHLBI definition was developed to enable
the clinician to easily ascertain values and make a Mets diagnosis in the office.
The more recently developed IDF definition mirrors the AHA/NHLBI definition in
order to maintain clinical utility. However, since the lower WC cut-off points
demarcating obesity found in the I DF definition are a requisite condition, this
directly impacts Mets prevalence (36).
The high-level prevalence estimates were observed for the ACE/AACE
and IDF definitions. A plausible reason for this is that requisite criteria of the
.

ACE/AACE and IDF are related to a high-level estimate of prevalence (phase -1)
and their focus emphasizing BMI or WC. With 66.3% of the US adult population
estimated to be overweight or obese (57), the eligibility pools for either of these
two definitions is quite large. A closer examination of body size . the obesity
requisite criteria identifies three possible reasons for the large eligibility pools.

. First, the requisite criterion for the ACE/AACE definition includes a BMI ·> 25
kg/m2 , thus capturing those who are both overweight and obese. Second, the
ACE/AACE requisite criteria classify everyone > 40 years of age a high-risk. A
closer look at Table 2 illustrates this would include two-thirds of the ·U .S.
population. And thirdly, the IDF requisite criterion for WC is ethnic specific, which
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not only enlarges the eligibility pool, but allows for more accurate, ethnically
sensitive prevalence · estimates. Until recently, epidemiological research utilized
National Institutes of Health (NIH) WC -cut-off points for all ethnic groups in the
US (56). Ethnic-specific WC cut-off points (which are often lower) are now
recommended due to the fact recent research has ·shown the co-morbidities
associated with body size or central obesity vary among populations (46, 75).

Mets and gender

When focusing on demographic Mets prevalence estimates, males were
found to have a greater overall prevalence in two of the five working definitions.
Males were also found to have a greater overall prevalence of -the Mets in
NHANES Il l (37). One explanation for this may be the higher prevalences of HTN
and hypertriglyceridemia found in males in NHANE S I l l . Furthermore, in the
CARDIA study (18) , a prospective study examining demographic characteristics
and modifiable cardiovascular risk profiles with the likelihood . of developing the
Mets in adult males and females, males were found to be .two to four times more
likely to have the Mets without abdominal adiposity, thus suggesting the
remaining Mets risk factors may cluster more in
_ males.
The lower prevalence estimates found among females in two of the five
definitions correspond to our findings of females being 23% to 30% less_ likely to
be diagnosed with the Mets. In NHANES 1 1 1 , Tong et al. (68) found men aged 3554 years to be more then twice as likely (OR 2.22, 95% -CI, 1.03-4.81 ) to have
the Mets when compared to women in the same age category. (OR ·1:.05, 95% C l ,
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0.40-2. 79). The transition from pre-to postmenopause is accompanied by many .
characteristics defining the Mets, including increases in central adiposity,
increases in both glucose and insulin levels, and often a shift to a more
atherogenic lipid profile (19). The decreased risk of being diagnosed with the
Mets found in our study may be explained by the protective effects of
endogenous estrogen found in pre-menopausal females (69), however, this is
still an unanswered question (68).
Nevertheless, the clustering of cardiovascular risk factors is prevalent in both
· males and females anct leads to an increase in CVD risk in both genders (73).

Mets and age
There is a strong positive association between the prevalence of the Mets
and age. Our study found males and females 60-69 years of age to be four to
eight times m?re likely to be diagnosed with Mets than. those 20-29 years of age.
Males and females age 35-64in NHANES Ill were found to be two to three times
more likely to be diagnosed with the Mets than those age 20-34 (59). This likely
occurs because of the increase in Mets risk factors (e.g: insu�in resistance,·
obesity) that accompanies the normal aging process (13, 33).

Mets and ethnicity
Specific to race/ethnicity, Mexican-Americans were found to have the
highest prevalence estimates and risk of the Mets across all five medical society ·
definitions. Mexican-Americans have been found to have greater prevalences of
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abdominal obesity and hypertriglyceridemia (38), and greater prevalences of
fasting hyperglycemia (25), compared to their non-Hispanic black and non- .
Hispanic white counterparts. All of these conditions represent either requisite
(phase 1) or threshold (phase 2) conditions for Mets diagnosis. Additionally, _the
clustering of cardiovascular risk factors associated with the Mets has been found
to be more common in Mexican-Americans (25, 38, 59), thus leading to the
higher prevalence rates found in this population.
Conversely, non-Hispanic blacks were found to have the lowest Mets
prevalence estimates and risk in three of the five medical society definitions (See
Tables 2 and 3). The differences in metabolic alterations associated with central
obesity may hold some the explanation for this racial disparity found between racial/ethnic groups. Despres (29) found blacks to have higher H DL-C levels and
a more cardioprotective lipoprotein profile for similar levels of abdominal
adiposity compared to whites. In NHANES Ill , non-Hispanic blacks were found to
have a lower prevalence of dyslipidemia than their non-Hispanic white and
Hispanic counterparts (58). This may be one reason non-Hispanic blacks were
found to have lower overall Mets prevalences in three of the five definitions. This
metabolic protection carried-by non-Hispanic blacks has been shown· to be the
result of carrying lower amounts of visceral fat for the same level of adiposity
compared to other populations (24, 45).
The. non-Hispanic white (EGIR) and other racial/ethnic (WHO) category
are found to have the lowest prevalence estimates when HTN diagnostic criteria
are raised from 1 30/85 nimHg to 1 40/90 ·mmHg in the WHO and EGIR definitions
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(See Table 2). This was not surprising knowing that non-Hispanic blacks have
greater prevalences of HTN (44, 58, 66). Interestingly, approximately 50% of
people with essential HTN have been found to be insulin resistant and·
hyperinsulinemic (61). Insulin resistance has been postulated by many to be the
core component of the Mets (2, 3, 5, 11,· 32; 34, 40, 62, 67). The coexistence of
insulin resistance and HTN would identify approximately half of the eligibility
pools for the WHO and EGIR definitions as being one condition away from Mets
diagnosis, thus greatly increasing the likelihood of diagnosis in a smaller at risk
eligibility pool. This relationship between insulin resistance and HTN warrants
continued investigation.

MetS and SES
Socioeconomic status is a well established marker commonly used by
epidemiologists (52). Outside of gender and race/ethnic background which are
genetically determined, in this study environmental and societal markers of
affluence were found to have the greatest relationship with risk and prevalence of
the Mets. Our study utilized the two most common surrogates of SES, education
and income. The relationship between SES and the core components of the .
Mets has been previously examined (12, 15, 23, 53, 54). In NHANES 1 1 1, Loucks
et al. (54) found socioeconomic position (SEP) to be associated with the Mets. in
non-Hispanic whites, ·non-Hispanic blacks, and Mexican-Americans, with the
association being greater in women. People with diabetes from a low SES have
been found to be at a greater risk for developing the Mets because they are
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more likely to be obese and hypertensive (23). Brunner et al. ( 15) found central
obesity, triglycerides, and high waist to hip ratios to be inversely associated with
SES. Additionally, in a landmark paper by Rose and Marmot (64) looking at risk
.
factors for CVD, overweight, obesity, and HTN, all conditions contributing to a
diagnosis of the Mets across all five medical society definitions, were reported to
be associated with a lower SES.

Study limitations
Our findings must be interpreted in light of the potential limitations. Among
the total number of criteria identified in all five definitions of the Mets, we were
unable to measure four criteria due to them not being available in the most recent
NHANES. First, oral glucose tolerance test (OGTT) values were not available.·
We utilized three markers of insulin resistance or diabetes included in the WHO
definition. These included IFG, T2D, and insulin in the top quartile .of the .
background population. Insulin in the top quartile of the background population
· and IFG but not diabetes was utilized in the EGIR definition, and I FG and
diabetes in the AHA/NHLBI (NCEP) definition (See Table 1). Second, the most
recent NHANES did not collect data on hip measurements. We utilized only the
BMI data for our obesity value in the WHO definition. Third, gestational diabetes
data, and lastly, data on polycystic ovary syndrome were not available for women
who may have had a history of these two conditions. Thus, in the ACE/AACE
high-risk requisite criteria we only included 1) family history of CVD, 2) known
CVD, 3) inactive lifestyle, 4) over 40 years of-age, and 5) ethnic populations at ·
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high-risk for T2D. Another limitation is the cross-sectional nature of our study,
precluding causation from being inferred.

Conclusion
In conclusion, the magnitude of Mets prevalence is highly dependent on
the medical society definition used. Thus, direct ·comparisons of prevalence
values across Mets studies may be severely limited. Future studies should
carefully consider which medical society definition to adopt in order to maximize
their ability to relate to findings from other studies. In addition, our study·may also
assist researchers to anticipate the magnitude of the expected prevalence they
will encounter in study populations based on the definition adopted, thus allowing
them to refine project methodologies (i.e. power analysis). Furthermore, · this
study will allow practitioners and researchers to continue dialogue· which may
lead to a consensus on which def_inition would be the best to employ·in both
clinical and research environments.
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APPENDIX B
Metabolic Syndrome and its Relationship to Total Physical Activity:
NHANES 1999-2002.

1 91

Abstract

In the past, the examination of the relationship between physical activity .(PA)
and the metabolic syndrome (MetS) has been restricted to leisure-time
physical activity. The 1999-2002 National Health and Nutrition Examination
Survey (NHANES I V) currently assesses PA across all. domains (leisure-time,
destinational, and domestic), allowing the .Mets to be examined from a global
perspective. Purpose: To explore the relationship between total PA (leisure- . .
time, destinational, and domestic) and the Mets among a national sample of
adults. Methods : This study included 4059 adults, 20 years and older who
completed the mobile examination center (MEC) examination in NHANES I V.
. Mets was defined based on the current National Cholesterol Education
Program-Adult Treatment Program Ill criteria. Each subject completed a PA ·
interview that measured all domains of . PA, and included the assessment of
intensity, frequency, and duration. Resu lts : The national age-adjusted .
prevalence for the Mets was 32.4%. Prevalence of the Mets among adults
meeting the ACSM/CDC recommendation was 21.8% .(met recommendation),
30.2% (insufficient), and 36.9% (physically inactive), demonstrating an
inverse relationship. Adults with the Mets performed significantly less PA
(827 MET-minutes per week) compared to those without the Mets (1076
MET-minutes per week). However, there was not a significant difference
between frequency of PA (per week) and PA duration (daily minutes),
suggesting that exercise intensity may be the best explanation for explaining
the difference adults with and without the Mets relative to the ACSM/CDC
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recommendatJon. Conclusion: Those with Mets are less likely to meet
ACSM/CDC recommendations for PA. Those with the Mets achieve less PA
than their counterparts due to the difference in intensity of the PA.
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NCEP Defined Metabolic Syn.drome
P revalence by PA Recommendation ·
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Figure B-1 . Inverse association of physical activity and the metabolic syndrome
when measuring physical activity from the parameters of the CDC/ACSM
physical activity public health recommendation, NHANES 1999-2002.
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Physical Activ ity and the Metabolic Syndrome
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Figure 8-2. Inverse association of physical activity when examining
MET·min·wk·1 and the risk of the metabolic syndrome in the United States adult
population aged �20 years in NHANES 1999-2002.
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AP�ENDIX C

Alternate Findings: The Association of Total Physical Activity with
the Metabolic Syndrome . . .

1 96

Abstract

This study also took a preliminary look at a more global physical activity
(PA) measure utilizing information on PA from three domains (LTPA, domestic,
and transportation). Data utilized to measure total PA was accessed from two
distinct N HANES questionnaire data files - the 'Physical activity' data file
(PAQ_C) and the 'physical activities individual activities file' (PAQIAF) ( 1 ). The
PAQ_C asked questions related to the frequency, intensity, and duration specific
to transportational and domestic PA performed ovenhe past-30 days (e.g. Over
the last 30 days, how often did you walk or cycle as a part of getting to or from
work, or school, or to do errands?). The PAQIAF is the second of the two files on
PA and includes more detailed information regarding 43-specific types of
moderate and vigorous LTPA. The combination of information from the two PA
files allowed us to create a global measure of PA to examine the possible inverse
association with metabolic syndrome risk. Appendix C includes replicate tables
also found in Part IV.
Table C-1 illustrates the prevalence of the metabolic syndrome according .
to the American Heart Association and National Heart, Lung, and Blood Institute
(AHA/NHLBI) definition by the Centers for Disease Control and Prevention and
the American College of Sports Medicine (CDC/ACSM) public health PA
recommendation and total weekly MET·minutes from all three domains of PA.
The prevalence of the metabolic syndrome among those meeting the current
CDC/ACSM PA recommendation (3) was 33.0% (95% Cl 30.0-36.0). The
prevalence among those reporting no PA (inactive) from any of the three
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domains was 41.6% (95% Cl 38.0-45.3), significantly greater than those meeting
the current public health recommendation.
Table C-2 depicts the relative risk odds ratio (OR) of a metabolic
syndrome diagnosis and the accumulation of increasing the metabolic risk score
(MSRS) by total weekly MET·minutes. Interestingly, we found an inverse
association (OR 0.76; 95% Cl 0.58-0.98) beginning at a volume of 1261.18
weekly MET-minutes, a much greater level than that found when examining the
results of Part I V which solely focused on LTPA (OR 0.65; 95% Cl 0.48-0.88)
(736.55 weekly MET·minutes). A similar inverse association was found for
increasing the MSRS (OR 0. 79; 95% Cl 0.64-0.96).
Table C-3 depicts the OR of a metabolic syndrome diagnosis and the . . .
increasing metabolic risk score MSRS by the CDC/ACSM public health PA
recommendation when focusing on total weekly MET·minutes. Those meeting
the current public health PA recommendation were found to be 31 % (OR 0.69;
95% Cl .057-0.84) less likely to have the metabolic syndrome and 25% less likely
(OR O.75; 95% Cl 0.64-0.88) to add an add itional risk factor to the MSRS
compared to those reporting no PA (inactive) from any of the three domains.
These associations were similar to those found in Part I V when examining LTPA;
however, the inverse relationships were n·ot as strong. This too warrants future
study.
One possible explanation for these conflicting results between LTPA and
Total PA resides with intensity of PA. Table C-4 compares the proportion of
vigorous MET-minutes among those who reported strictly LTPA and those
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reporting PA from up to all three domains. When examining the rirst two levels . of
PA, approximately 10%-15% of the weekly MET·minutes come from vigorous
activities for LTPA and total PA. However, as the volume of LTPA MET·minutes
increases, the proportion of those MET·minutes coming from vigorous PA also
increases. Those accumulating the greatest volume of LTPA (>1360.15
MET·minutes) acquired 45.7% of their MET-minutes from vigorous PA. Those
accumulating the greatest volume of total PA (2298.66 MET-minutes) only
acquired 27.6% of their MET·minutes from vigorous PA.
The level and appearance of protection associated with PA and the
metabolic syndrome clearly differs when examining multiple domains (LTPA,
domestic, and transportation), versus one domain,· in this case LTPA. Perhaps·
the reason Ford et al. in an earlier NHANES metabolic syndrome and PA study
. (2) did not find protection associated with PA was because he utilized multiple
domains (LTPA and domestic). These data suggest intensity, one · of the
parameters of PA volume, may play an important role in .the relationship between
PA and the metabolic syndrome. Future studies need to examine all these .
parameters to elucidate which of these components may be related to these
conflicting outcomes. This type of information may assist health care
professionals to understand how to prescribe PA to people for prevention and
disease control specific to the metabolic syndrome.
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Table C-1. Metabolic Syndrome Prevalence According to the AHA/NHLBI
Definition by CDC/ACSM Public Health PA Recommendation* and Total PA
MET·Minutes from All Three Domainst Among U.S: Adults �20 Years - NHANES
1999-2004.
- Age-adjusted
prevalence
%
Weekly LTPA MET minutes
0.0
41 .1
41 .4
>0.0 - �283.43
36.2
>283.43 - �675.48
35.3
>675 .48 - �1 261 . 1 8
34. 3
> 1 261 . 1 8 - �2298 .66
>2298.66
31 .0
Inactive
Insufficiently active;
Meets Recommendation*

%
4 1 .6
38.2
33.0

95% CI

37.6, 44.6
37.3, 45. 5
32.6, 39. 8
31 .3, 39.3
30.5, 38. 1
27. 1 , 35. 0
95% - CI
38.0, 45. 3
35.9, 40.4
30.0, 36. 0

CDC/ACSM=Centers for Disease Control and Prevention / American College of Sports Medicine.
1
MET=Metabolic equivalent (1 MET= 3.5 mVkg/min- )
• Every us· adult should accumulate 30 minutes or more of moderate-intensity physical activity on most, preferably
all, days of the week (3).
tPA from LTPA, domestic PA, and transportational PA.
;Physically active but insufficient to meet CDC/ACSM recommendation (3).
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Table C-2. Odds ratios of Metabolic Syndrome diagnosis and Increasing ,
Metabolic Syndrome Risk Score (MSRS) by Weekly MET-minutes from All Three
Domains of PA*: NHANES 1999-2004.
Metabolic syndrome risk by
total PA level

Weekly MET minutes
0.0
>0.0 - �283.43
>283.43 - �675.48
>675.48 - �1 261 . 1 8
> 1 261 . 1 8 - �2298.66
>2298.66

Odds ratio
1 .00
1 .15
0.84
0.85
0.76
0.64

95% CI
0.88,
0.66,
0.66,
0.58,
0.49,

1 .51
1 .08
1 .10
0.98
0.83

P value
for trend
0.0006

Risk of increasing
MSRS

Odds ratio
1 .00
1 .27
0.92
0.91
0.79
0.69

95% CI
1 .00, 1 .61
0.73, 1 . 1 5
0.73, 1 . 1 4
0.64, 0.96
0.57, 0.84

Covariates adjusted for in the model include gender, age, race/ethnicity, education, income, smoking status,
alcohol intake, family history of heart disease, and family history of diabetes.
1
MET=Metabolic equivalent (1 MET= 3.5 mVkg/min- )
*PA from LTPA, domestic, and transportation.

20 1

P value
for trend
0. 0003

Table C-3. Odds ratios of Metabolic Syndrome diagnosis and Increasing Metabolic
Syndrome Risk Score (MSRS) by CDC/ACSM public health PA recommendation· and . ·
Total PA from All Three Domainst: NHANES 1999..2004
LTPA Level
Inactive
Insufficiently active;
Meets PA recommendation•

Metabolic syndrome risk by
total PA level

Odds ratio

95% Cl

1.00

0.88
0.69

0.71 , 1 .09
0.57, 0 .84

P value
for trend
· 0.00 1 0

Risk of increasing
- MSRS

Odds ratio

95% CI

1 .00
0.98
0.75

0.81 , 1 . 1 8
0.64, 0.88

-

Covariates adjusted for in the model include gender, age, race/ethnicity, education, income, smoking status,
alcohol intake, family history of heart disease, and family history of diabetes.
CDC/ACSM=Centers for Disease Control and Prevention / American College of Sports Medicine.
CV= Cardiovascular disease.
• Every US adult should accumulate 30 minutes or more of moderate-Intensity physical activity on most, preferably
all, days of the week (3):
tPA from LTPA, domestic PA, and transportational PA.
; Physically active but insufficient to meet CDC/ACSM recommendation (3).
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P value
for trend
0.001 5

Table C-4. Proportion of Vigorous Intensity PA Comparing Total
PA from All Three Domains* and PA from those Reporting Only
· ·
LTPAt : NHANES 1999-2004.
LTPA MET·minutes

0.0
>0.0 - �1 56.24
>1 56.24 - �393. 1 0
>393. 1 0 - �736.55
>736.55 - �1 360. 1 5
>1 360. 1 5

% _from
vigorous PA

1 0.0
1 5.8
24.8
34.5
45.7

% from

Total MET·minutes*

vigorous PA Weekll MET minutes
0.0
>0.0 - �283.43
· 9.4
>283.43 - �675.48
1 5.7
>675.48 - �1 261 . 1 8
21 .4
> 1 261 . 1 8 - �2298.66
25.9
>2298.66
27.6

*PA from LTPA, domestic PA, and transportational PA.
t LTPA=_ leisure-time physical activity
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